Constellation Brands (STZ) 10-Q5 Oct 232024 Q2 Quarterly reportFinancial data

Company Profile

Cover Page

Cover Page - shares	6 Months Ended
Cover Page - shares	Aug. 31, 2023	Sep. 30, 2023
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Aug. 31, 2023
Document Transition Report	false
Entity File Number	001-08495
Entity Registrant Name	CONSTELLATION BRANDS, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	16-0716709
Entity Address, Address Line One	207 High Point Drive
Entity Address, Address Line Two	Building 100
Entity Address, City or Town	Victor
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	14564
City Area Code	585
Local Phone Number	678-7100
Title of 12(b) Security	Class A Common Stock
Trading Symbol	STZ
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0000016918
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--02-29
Class A Stock
Entity Common Stock, Shares Outstanding		183,662,681
Class 1 Common Stock
Entity Common Stock, Shares Outstanding		23,241

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Aug. 31, 2023	Feb. 28, 2023
Current assets:
Cash and cash equivalents	$ 83.3	$ 133.5
Accounts receivable	933.2	901.6
Inventories	1,814	1,898.7
Prepaid expenses and other	603.8	562.3
Total current assets	3,434.3	3,496.1
Property, plant, and equipment	7,580.3	6,865.2
Goodwill	7,985.6	7,925.4
Intangible assets	2,734.5	2,728.1
Equity method investments	277.1	663.3
Deferred income taxes	2,147.6	2,193.3
Other assets	770.6	790.9
Total assets	24,930	24,662.3
Current liabilities:
Short-term borrowings	467.4	1,165.3
Current maturities of long-term debt	558.3	9.5
Accounts payable	978.8	941.5
Other accrued expenses and liabilities	853	852
Total current liabilities	2,857.5	2,968.3
Long-term debt, less current maturities	10,680.8	11,286.5
Deferred income taxes and other liabilities	1,667.7	1,673.6
Total liabilities	15,206	15,928.4
Commitments and contingencies
CBI stockholders’ equity:
Additional paid-in capital	1,998.8	1,903
Retained earnings	12,842.7	12,343.9
Accumulated other comprehensive income (loss)	434.4	28.5
Total stockholders’ equity before treasury stock adjustments	15,278	14,277.5
Total CBI stockholders’ equity	9,390.8	8,413.6
Noncontrolling interests	333.2	320.3
Total stockholders’ equity	9,724	8,733.9
Total liabilities and stockholders’ equity	24,930	24,662.3
Class A Stock
CBI stockholders’ equity:
Common stock, value	2.1	2.1
Less: Treasury stock –	$ (5,887.2)	$ (5,863.9)

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - Class A Stock - $ / shares	Aug. 31, 2023	Feb. 28, 2023
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	322,000,000	322,000,000
Common stock, shares issued (in shares)	212,697,728	212,697,428
Treasury stock, at cost (in shares)	29,038,592	29,498,426

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($) shares in Thousands, $ in Millions	3 Months Ended		6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022
Sales	$ 3,053	$ 2,864.3	$ 5,752.5	$ 5,405
Excise taxes	(216.2)	(209.2)	(400.8)	(386.7)
Net sales	2,836.8	2,655.1	5,351.7	5,018.3
Cost of product sold	(1,386.9)	(1,329.2)	(2,644)	(2,437.4)
Gross profit	1,449.9	1,325.9	2,707.7	2,580.9
Selling, general, and administrative expenses	(471.2)	(512.8)	(964.3)	(951.4)
Operating income (loss)	978.7	813.1	1,743.4	1,629.5
Income (loss) from unconsolidated investments	(20.2)	(1,719.1)	(435.6)	(1,907)
Interest expense	(110.6)	(94.3)	(228.8)	(182.8)
Loss on extinguishment of debt	0	(8)	(0.7)	(23.3)
Income (loss) before income taxes	847.9	(1,008.3)	1,078.3	(483.6)
(Provision for) benefit from income taxes	(147.2)	(132.4)	(238.4)	(257.8)
Net income (loss)	700.7	(1,140.7)	839.9	(741.4)
Net (income) loss attributable to noncontrolling interests	(10.7)	(10.5)	(14)	(20.3)
Net income (loss) attributable to CBI	690	(1,151.2)	825.9	(761.7)
Comprehensive income (loss)	901.5	(1,334.2)	1,266	(675.9)
Comprehensive (income) loss attributable to noncontrolling interests	(20)	(6.1)	(34.2)	(28.5)
Comprehensive income (loss) attributable to CBI	881.5	(1,340.3)	1,231.8	(704.4)
Class A Stock
Net income (loss) attributable to CBI	$ 690	$ (1,018.2)	$ 825.9	$ (674.2)
Net income (loss) per common share attributable to CBI:
Net income (loss) per common share attributable to CBI - basic (in dollars per share)	$ 3.76	$ (6.30)	$ 4.50	$ (4.13)
Net income (loss) per common share attributable to CBI - diluted (in dollars per share)	$ 3.74	$ (6.30)	$ 4.49	$ (4.13)
Weighted average common shares outstanding:
Weighted average common shares outstanding - basic (in shares)	183,498	161,730	183,384	163,532
Weighted average common shares outstanding - diluted (in shares)	184,277	161,730	184,074	163,532
Cash dividends declared per common share:
Cash dividends declared per common share (in dollars per share)	$ 0.89	$ 0.80	$ 1.78	$ 1.60
Class B Stock
Net income (loss) attributable to CBI		$ (133)		$ (87.5)
Net income (loss) per common share attributable to CBI:
Net income (loss) per common share attributable to CBI - basic (in dollars per share)		$ (5.73)		$ (3.77)
Net income (loss) per common share attributable to CBI - diluted (in dollars per share)		$ (5.73)		$ (3.77)
Weighted average common shares outstanding:
Weighted average common shares outstanding - basic (in shares)		23,206		23,206
Weighted average common shares outstanding - diluted (in shares)		23,206		23,206
Cash dividends declared per common share:
Cash dividends declared per common share (in dollars per share)		$ 0.72		$ 1.44

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Millions	Total	Class A Stock	Common Stock Class A Stock	Common Stock Class B Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Treasury Stock	Non-controlling Interests
Stockholders' equity, beginning of period at Feb. 28, 2022	$ 12,047.8		$ 1.9	$ 0.3	$ 1,808.9	$ 14,505.4	$ (412.7)	$ (4,171.9)	$ 315.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	399.3					389.5			9.8
Other comprehensive income (loss), net of income tax effect	259						246.4		12.6
Comprehensive income (loss)	658.3
Repurchase of shares	(1,007.6)							(1,007.6)
Dividends declared	(148.7)					(148.7)
Noncontrolling interest distributions	(11.2)								(11.2)
Shares issued under equity compensation plans	3.2				(0.6)			3.8
Stock-based compensation	16.7				16.7
Stockholders' equity, end of period at May. 31, 2022	11,558.5		1.9	0.3	1,825	14,746.2	(166.3)	(5,175.7)	327.1
Stockholders' equity, beginning of period at Feb. 28, 2022	12,047.8		1.9	0.3	1,808.9	14,505.4	(412.7)	(4,171.9)	315.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(741.4)
Other comprehensive income (loss), net of income tax effect							57.3
Comprehensive income (loss)	(675.9)
Stockholders' equity, end of period at Aug. 31, 2022	9,710.9		1.9	0.3	1,860.4	13,448.4	(355.4)	(5,566.6)	321.9
Stockholders' equity, beginning of period at May. 31, 2022	11,558.5		1.9	0.3	1,825	14,746.2	(166.3)	(5,175.7)	327.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(1,140.7)					(1,151.2)			10.5
Other comprehensive income (loss), net of income tax effect	(193.5)						(189.1)		(4.4)
Comprehensive income (loss)	(1,334.2)
Repurchase of shares	(392.9)							(392.9)
Dividends declared	(146.6)					(146.6)
Noncontrolling interest distributions	(11.3)								(11.3)
Shares issued under equity compensation plans	16.5				14.5			2
Stock-based compensation	20.9				20.9
Stockholders' equity, end of period at Aug. 31, 2022	9,710.9		1.9	$ 0.3	1,860.4	13,448.4	(355.4)	(5,566.6)	321.9
Stockholders' equity, beginning of period at Feb. 28, 2023	8,733.9		2.1		1,903	12,343.9	28.5	(5,863.9)	320.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	139.2					135.9			3.3
Other comprehensive income (loss), net of income tax effect	225.3						214.4		10.9
Comprehensive income (loss)	364.5
Repurchase of shares	(35)							(35)
Dividends declared	(163.1)					(163.1)
Noncontrolling interest distributions	(11.3)								(11.3)
Shares issued under equity compensation plans	4.7				0.6			4.1
Stock-based compensation	14.5				14.5
Stockholders' equity, end of period at May. 31, 2023	8,908.2		2.1		1,918.1	12,316.7	242.9	(5,894.8)	323.2
Stockholders' equity, beginning of period at Feb. 28, 2023	8,733.9		2.1		1,903	12,343.9	28.5	(5,863.9)	320.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	839.9
Other comprehensive income (loss), net of income tax effect							405.9
Comprehensive income (loss)	1,266
Repurchase of shares		$ (35)
Stockholders' equity, end of period at Aug. 31, 2023	9,724		2.1		1,998.8	12,842.7	434.4	(5,887.2)	333.2
Stockholders' equity, beginning of period at May. 31, 2023	8,908.2		2.1		1,918.1	12,316.7	242.9	(5,894.8)	323.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	700.7					690			10.7
Other comprehensive income (loss), net of income tax effect	200.8						191.5		9.3
Comprehensive income (loss)	901.5
Dividends declared	(164)					(164)
Noncontrolling interest distributions	(10)								(10)
Shares issued under equity compensation plans	70.2				62.6			7.6
Stock-based compensation	18.1				18.1
Stockholders' equity, end of period at Aug. 31, 2023	$ 9,724		$ 2.1		$ 1,998.8	$ 12,842.7	$ 434.4	$ (5,887.2)	$ 333.2

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ 839.9	$ (741.4)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Unrealized net (gain) loss on securities measured at fair value	74.4	31.7
Deferred tax provision (benefit)	26.3	208.6
Depreciation	213.7	183.5
Stock-based compensation	32.5	37.8
Equity in (earnings) losses of equity method investees and related activities, net of distributed earnings	226.5	815.6
Noncash lease expense	43.3	44.4
Amortization of debt issuance costs and loss on extinguishment of debt	6.1	28.2
Impairment of equity method investments	135.8	1,060.3
Gain (loss) on settlement of Pre-issuance hedge contracts	1.2	20.7
Change in operating assets and liabilities, net of effects from purchase and sale of business:
Accounts receivable	(30)	(84.8)
Inventories	81.3	(86.3)
Prepaid expenses and other current assets	(47.9)	165.6
Accounts payable	(56.4)	188.9
Deferred revenue	17.6	9.5
Other accrued expenses and liabilities	(33.9)	(287.7)
Other	91.6	59.7
Total adjustments	782.1	2,395.7
Net cash provided by (used in) operating activities	1,622	1,654.3
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant, and equipment	(582)	(435)
Purchase of business, net of cash acquired	(7.5)	(37.2)
Investments in equity method investees and securities	(27.6)	(21)
Proceeds from sale of assets	14.8	6.6
Proceeds from sale of business	5.4	0
Other investing activities	(4)	0.6
Net cash provided by (used in) investing activities	(600.9)	(486)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of long-term debt	744.8	1,846.8
Principal payments of long-term debt	(805.1)	(1,654.7)
Net proceeds from (repayments of) short-term borrowings	(697.9)	340.9
Dividends paid	(327.6)	(295.3)
Purchases of treasury stock	(35)	(1,400.5)
Proceeds from shares issued under equity compensation plans	86.2	30.5
Payments of minimum tax withholdings on stock-based payment awards	(11.2)	(10.5)
Payments of debt issuance, debt extinguishment, and other financing costs	(5.3)	(33.3)
Distributions to noncontrolling interests	(21.3)	(22.5)
Net cash provided by (used in) financing activities	(1,072.4)	(1,198.6)
Effect of exchange rate changes on cash and cash equivalents	1.1	(4)
Net increase (decrease) in cash and cash equivalents	(50.2)	(34.3)
Cash and cash equivalents, beginning of period	133.5	199.4
Cash and cash equivalents, end of period	83.3	165.1
Supplemental disclosures of noncash investing and financing activities
Additions to property, plant, and equipment	$ 206	$ 69.1

Basis of Presentation

Basis of Presentation	6 Months Ended
Basis of Presentation	Aug. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION	BASIS OF PRESENTATION We have prepared the Financial Statements, without audit, pursuant to the rules and regulations of the SEC applicable to quarterly reporting on Form 10-Q and reflect, in our opinion, all adjustments necessary to present fairly our financial information. All such adjustments are of a normal recurring nature. Certain information and footnote disclosures normally included in financial statements, prepared in accordance with generally accepted accounting principles, have been condensed or omitted as permitted by such rules and regulations. These Financial Statements should be read in conjunction with the consolidated financial statements and related notes included in the 2023 Annual Report. Results of operations for interim periods are not necessarily indicative of annual results. Effective May 31, 2023, we changed our internal management financial reporting to consist of two business divisions: (i) Beer and (ii) Wine and Spirits and we now report our operating results in three segments: (i) Beer, (ii) Wine and Spirits, and (iii) Corporate Operations and Other following the removal of the Canopy operating segment. All financial information for the six months and three months ended August 31, 2022, has been restated to conform to the new segment presentation. For additional information, refer to Note 13.

Inventories

Inventories	6 Months Ended
Inventories	Aug. 31, 2023
Inventory Disclosure [Abstract]
INVENTORIES	INVENTORIES Inventories are stated at the lower of cost (primarily computed in accordance with the first-in, first-out method) or net realizable value. Elements of cost include materials, labor, and overhead and consist of the following: August 31, February 28, (in millions) Raw materials and supplies $ 226.4 $ 245.5 In-process inventories 930.2 967.8 Finished case goods 657.4 685.4 $ 1,814.0 $ 1,898.7

Derivative Instruments

Derivative Instruments	6 Months Ended
Derivative Instruments	Aug. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE INSTRUMENTS	DERIVATIVE INSTRUMENTS Overview Our risk management and derivative accounting policies are presented in Notes 1 and 6 of our consolidated financial statements included in our 2023 Annual Report and have not changed significantly for the six months and three months ended August 31, 2023. We have an investment in certain equity securities and other rights which provide us with the option to purchase an additional ownership interest in the equity securities of Canopy (see Note 7). This investment is included in other assets and is accounted for at fair value, with the net gain (loss) from the changes in fair value of this investment recognized in income (loss) from unconsolidated investments (see Note 4). We intend to surrender this investment for cancellation upon completion of the Canopy Transaction and if we elect to convert our Canopy common shares into Exchangeable Shares. The aggregate notional value of outstanding derivative instruments is as follows: August 31, February 28, (in millions) Derivative instruments designated as hedging instruments Foreign currency contracts $ 1,904.9 $ 1,969.5 Derivative instruments not designated as hedging instruments Foreign currency contracts $ 810.9 $ 831.7 Commodity derivative contracts $ 344.6 $ 416.5 Credit risk We are exposed to credit-related losses if the counterparties to our derivative contracts default. This credit risk is limited to the fair value of the derivative contracts. To manage this risk, we contract only with major financial institutions that have earned investment-grade credit ratings and with whom we have standard International Swaps and Derivatives Association agreements which allow for net settlement of the derivative contracts. We have also established counterparty credit guidelines that are regularly monitored. Because of these safeguards, we believe the risk of loss from counterparty default to be immaterial. In addition, our derivative instruments are not subject to credit rating contingencies or collateral requirements. As of August 31, 2023, the estimated fair value of derivative instruments in a net liability position due to counterparties was $1.7 million. If we were required to settle the net liability position under these derivative instruments on August 31, 2023, we would have had sufficient available liquidity on hand to satisfy this obligation. Results of period derivative activity The estimated fair value and location of our derivative instruments on our balance sheets are as follows (see Note 4): Assets Liabilities August 31, February 28, August 31, February 28, (in millions) Derivative instruments designated as hedging instruments Foreign currency contracts: Prepaid expenses and other $ 156.0 $ 109.1 Other accrued expenses and liabilities $ 7.6 $ 9.8 Other assets $ 173.8 $ 134.5 Deferred income taxes and other liabilities $ 2.0 $ 3.5 Derivative instruments not designated as hedging instruments Foreign currency contracts: Prepaid expenses and other $ 5.0 $ 5.9 Other accrued expenses and liabilities $ 2.7 $ 3.9 Commodity derivative contracts: Prepaid expenses and other $ 14.6 $ 21.2 Other accrued expenses and liabilities $ 22.2 $ 19.5 Other assets $ 3.3 $ 4.6 Deferred income taxes and other liabilities $ 6.2 $ 8.3 The principal effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, as well as OCI, net of income tax effect, is as follows: Derivative Instruments in Net Location of Net Gain (Loss) Net (in millions) For the Six Months Ended August 31, 2023 Foreign currency contracts $ 149.9 Sales $ (0.2) Cost of product sold 65.7 Pre-issuance hedge contracts 0.6 Interest expense (0.3) $ 150.5 $ 65.2 For the Six Months Ended August 31, 2022 Foreign currency contracts $ 71.3 Sales $ (1.2) Cost of product sold 21.9 Pre-issuance hedge contracts 15.7 Interest expense (0.6) $ 87.0 $ 20.1 For the Three Months Ended August 31, 2023 Foreign currency contracts $ 70.6 Sales $ (0.2) Cost of product sold 39.3 Pre-issuance hedge contracts — Interest expense (0.1) $ 70.6 $ 39.0 For the Three Months Ended August 31, 2022 Foreign currency contracts $ (8.2) Sales $ (0.6) Cost of product sold 10.8 Pre-issuance hedge contracts — Interest expense (0.1) $ (8.2) $ 10.1 We expect $130.3 million of net gains, net of income tax effect, to be reclassified from AOCI to our results of operations within the next 12 months. The effect of our undesignated derivative instruments on our results of operations is as follows: Derivative Instruments Not Location of Net Gain (Loss) Net (in millions) For the Six Months Ended August 31, 2023 Commodity derivative contracts Cost of product sold $ (15.6) Foreign currency contracts Selling, general, and administrative expenses 22.5 $ 6.9 Derivative Instruments Not Location of Net Gain (Loss) Net (in millions) For the Six Months Ended August 31, 2022 Commodity derivative contracts Cost of product sold $ 33.1 Foreign currency contracts Selling, general, and administrative expenses (2.6) $ 30.5 For the Three Months Ended August 31, 2023 Commodity derivative contracts Cost of product sold $ 19.1 Foreign currency contracts Selling, general, and administrative expenses 9.8 $ 28.9 For the Three Months Ended August 31, 2022 Commodity derivative contracts Cost of product sold $ (15.4) Foreign currency contracts Selling, general, and administrative expenses (8.8) $ (24.2)

Fair Value of Financial Instrum

Fair Value of Financial Instruments	6 Months Ended
Fair Value of Financial Instruments	Aug. 31, 2023
Fair Value Disclosures [Abstract]
FAIR VALUE OF FINANCIAL INSTRUMENTS	FAIR VALUE OF FINANCIAL INSTRUMENTS Authoritative guidance establishes a framework for measuring fair value, including a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. The hierarchy includes three levels: • Level 1 inputs are quoted prices in active markets for identical assets or liabilities; • Level 2 inputs include data points that are observable such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical assets or similar assets or liabilities in markets that are not active, and inputs (other than quoted prices) such as volatility, interest rates, and yield curves that are observable for the asset or liability, either directly or indirectly; and • Level 3 inputs are unobservable data points for the asset or liability, and include situations where there is little, if any, market activity for the asset or liability. Fair value methodology The following methods and assumptions are used to estimate the fair value of our financial instruments: Foreign currency and commodity derivative contracts The fair value is estimated using market-based inputs, obtained from independent pricing services, entered into valuation models. These valuation models require various inputs, including contractual terms, market foreign exchange prices, market commodity prices, interest-rate yield curves, and currency volatilities, as applicable (Level 2 fair value measurement). Interest rate swap and Pre-issuance hedge contracts The fair value is estimated based on quoted market prices from respective counterparties. Quotes are corroborated by using discounted cash flow calculations based upon forward interest-rate yield curves, which are obtained from independent pricing services (Level 2 fair value measurement). Canopy investment In April 2023, we extended the maturity of the remaining C$100.0 million principal amount of our Canopy Debt Securities by exchanging them for the 2023 Canopy Promissory Note. As such, our investment in Canopy is comprised of the (i) Canopy Equity Method Investment, (ii) November 2018 Canopy Warrants, and (iii) 2023 Canopy Promissory Note. The November 2018 Canopy Warrants and the 2023 Canopy Promissory Note are measured at fair value. Effective as of May 31, 2023, we determined that neither of these instruments had future economic value given Canopy’s stock price relative to the exercise price of the warrants and the substantial doubt about Canopy’s ability to continue as a going concern, as disclosed by Canopy, prior to the maturity of the note. Accordingly, the fair value of the remaining balances for these instruments were determined to be zero. This reduction in fair value is included in income (loss) from unconsolidated investments within our consolidated results of operations for the six months ended August 31, 2023. If the Canopy Amendment is authorized by Canopy’s shareholders, we intend to negotiate an exchange of the 2023 Canopy Promissory Note for Exchangeable Shares, although neither we nor Canopy has any binding obligation to do so, and we also intend to surrender the November 2018 Canopy Warrants for cancellation upon completion of the Canopy Transaction and if we elect to convert our Canopy common shares into Exchangeable Shares. Short-term borrowings Our short-term borrowings consist of our commercial paper program and the revolving credit facility under our senior credit facility. The revolving credit facility is a variable interest rate bearing note with a fixed margin, adjustable based upon our debt rating (as defined in our senior credit facility). For these short-term borrowings, the carrying value approximates the fair value. Long-term debt The fair value of our fixed interest rate long-term debt is estimated by discounting cash flows using interest rates currently available for debt with similar terms and maturities (Level 2 fair value measurement). As of August 31, 2023, the carrying amount of long-term debt, including the current portion, was $11,239.1 million, compared with an estimated fair value of $10,311.8 million. As of February 28, 2023, the carrying amount of long-term debt, including the current portion, was $11,296.0 million, compared with an estimated fair value of $10,236.0 million. The carrying amounts of certain of our financial instruments, including cash and cash equivalents, accounts receivable, and accounts payable, approximate fair value as of August 31, 2023, and February 28, 2023, due to the relatively short maturity of these instruments. Recurring basis measurements The following table presents our financial assets and liabilities measured at estimated fair value on a recurring basis: Fair Value Measurements Using Quoted Significant Significant Total (in millions) August 31, 2023 Assets: Foreign currency contracts $ — $ 334.8 $ — $ 334.8 Commodity derivative contracts $ — $ 17.9 $ — $ 17.9 Liabilities: Foreign currency contracts $ — $ 12.3 $ — $ 12.3 Commodity derivative contracts $ — $ 28.4 $ — $ 28.4 Fair Value Measurements Using Quoted Significant Significant Total (in millions) February 28, 2023 Assets: Foreign currency contracts $ — $ 249.5 $ — $ 249.5 Commodity derivative contracts $ — $ 25.8 $ — $ 25.8 November 2018 Canopy Warrants $ — $ 0.2 $ — $ 0.2 Canopy Debt Securities $ — $ 69.6 $ — $ 69.6 Liabilities: Foreign currency contracts $ — $ 17.2 $ — $ 17.2 Commodity derivative contracts $ — $ 27.8 $ — $ 27.8 Nonrecurring basis measurements The following table presents our assets and liabilities measured at estimated fair value on a nonrecurring basis for which an impairment assessment was performed for the periods presented: Fair Value Measurements Using Quoted Significant Significant Total Losses (in millions) For the Six Months Ended August 31, 2023 Equity method investments (1) $ 97.8 $ 2.6 $ — $ 135.8 For the Six Months Ended August 31, 2022 Equity method investments $ 634.8 $ — $ — $ 1,060.3 (1) As of August 31, 2023, the carrying value of the Canopy Equity Method Investment exceeded the fair value (Level 1 fair value measurement). We evaluated and determined there was not an other-than-temporary impairment. Our conclusion was based primarily on the period of time for which the fair value had been less than the carrying value, including Canopy’s stock price recovery above our carrying value following quarter-end. We will continue to evaluate the Canopy Equity Method Investment for an other-than-temporary impairment. Equity method investments As of August 31, 2023, we evaluated certain equity method investments, made through our corporate venture capital function, and determined there were other-than-temporary impairments due to business underperformance. Investments with a carrying value of $14.9 million were written down to an estimated fair value of $2.6 million, resulting in an impairment of $12.3 million. These investments are part of the Corporate Operations and Other segment. This loss from impairment was included in income (loss) from unconsolidated investments within our consolidated results for the six months and three months ended August 31, 2023. The estimated fair value was based largely on observable prices for similar assets. We evaluated the Canopy Equity Method Investment as of May 31, 2023, and determined there was an other-than-temporary impairment. Our conclusion was based on several contributing factors, including: (i) the fair value being less than the carrying value and the uncertainty surrounding Canopy’s stock price recovering in the near-term, (ii) Canopy recorded significant costs in its fourth quarter of fiscal 2023 results designed to align its Canadian cannabis operations and resources in response to continued unfavorable market trends, (iii) the substantial doubt about Canopy’s ability to continue as a going concern, as disclosed by Canopy, and (iv) C anopy’s identification of material misstatements in certain of its previously reported financial results related to sales in its BioSteel reporting unit that were accounted for incorrectly, including the recording of a goodwill impairment during its restated second quarter of fiscal 2023. As a result, the Canopy Equity Method Investment with a carrying value of $266.2 million was written down to its estimated fair value of $142.7 million, resulting in an impairment of $123.5 million. This loss from impairment was included in income (loss) from unconsolidated investments within our consolidated results for the six months ended August 31, 2023. The estimated fair value was determined based on the closing price of the underlying equity security as of May 31, 2023. We evaluated the Canopy Equity Method Investment as of August 31, 2022, and determined there was an other-than-temporary impairment based on several contributing factors, including: (i) the period of time for which the fair value had been less than the carrying value and the uncertainty surrounding Canopy’s stock price recovering in the near-term, (ii) Canopy recording a significant impairment of goodwill related to its cannabis operations during its three months ended June 30, 2022, and (iii) the uncertainty of U.S. federal cannabis permissibility. As a result, the Canopy Equity Method Investment with a carrying value of $1,695.1 million was written down to its estimated fair value of $634.8 million, resulting in an impairment of $1,060.3 million. This loss from impairment was included in income (loss) from unconsolidated investments within our consolidated results for the six months and three months ended August 31, 2022. The estimated fair value was determined based on the closing price of the underlying equity security as of August 31, 2022.

Goodwill

Goodwill	6 Months Ended
Goodwill	Aug. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL	GOODWILL The changes in the carrying amount of goodwill are as follows: Beer Wine and Spirits Consolidated (in millions) Balance, February 28, 2022 $ 5,120.7 $ 2,741.7 $ 7,862.4 Purchase accounting allocations (1) — 26.3 26.3 Wine Divestiture — (24.5) (24.5) Foreign currency translation adjustments 68.2 (7.0) 61.2 Balance, February 28, 2023 5,188.9 2,736.5 7,925.4 Purchase accounting allocations (2) — 4.2 4.2 Foreign currency translation adjustments 58.1 (2.1) 56.0 Balance, August 31, 2023 $ 5,247.0 $ 2,738.6 $ 7,985.6 (1) Purchase accounting allocations associated with the acquisitions of Austin Cocktails, Lingua Franca, and My Favorite Neighbor, LLC. (2) Preliminary purchase accounting allocation associated with the June 2023 acquisition of the Domaine Curry wine brand. Divestitures Craft Beer Divestitures In June 2023, we completed the Craft Beer Divestitures. Prior to the Craft Beer Divestitures, we recorded the results of operations of such craft beer brands in the Beer segment. Wine Divestiture On October 6, 2022, we sold certain of our mainstream and premium wine brands and related inventory. The net cash proceeds from the Wine Divestiture were utilized primarily to reduce outstanding borrowings. Prior to the Wine Divestiture, we recorded the results of operations of these brands in the Wine and Spirits segment. Acquisitions Austin Cocktails In April 2022, we acquired the remaining 73% ownership interest in Austin Cocktails, which included a portfolio of small batch, RTD cocktails. This transaction primarily included the acquisition of goodwill and a trademark. In addition, the purchase price for Austin Cocktails includes an earn-out over five years based on performance. The results of operations of Austin Cocktails are reported in the Wine and Spirits segment and have been included in our consolidated results of operations from the date of acquisition. Lingua Franca In March 2022, we acquired the Lingua Franca business, including a collection of Oregon-based luxury wines, a vineyard, and a production facility. This transaction also included the acquisition of a trademark and inventory. In addition, the purchase price for Lingua Franca includes an earn-out over seven years based on performance. The results of operations of Lingua Franca are reported in the Wine and Spirits segment and have been included in our consolidated results of operations from the date of acquisition.

Intangible Assets

Intangible Assets	6 Months Ended
Intangible Assets	Aug. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSETS	INTANGIBLE ASSETS The major components of intangible assets are as follows: August 31, 2023 February 28, 2023 Gross Net Gross Net (in millions) Amortizable intangible assets Customer relationships $ 85.3 $ 16.8 $ 85.7 $ 17.7 Other 20.4 — 20.8 — Total $ 105.7 16.8 $ 106.5 17.7 Nonamortizable intangible assets Trademarks 2,717.7 2,710.4 Total intangible assets $ 2,734.5 $ 2,728.1 We did not incur costs to renew or extend the term of acquired intangible assets for the six months and three months ended August 31, 2023, and August 31, 2022. Net carrying amount represents the gross carrying value net of accumulated amortization.

Equity Method Investments

Equity Method Investments	6 Months Ended
Equity Method Investments	Aug. 31, 2023
Equity Method Investments and Joint Ventures [Abstract]
EQUITY METHOD INVESTMENTS	EQUITY METHOD INVESTMENTS Our equity method investments are as follows: August 31, 2023 February 28, 2023 Carrying Value Ownership Percentage Carrying Value Ownership Percentage (in millions) Canopy Equity Method Investment (1) $ 134.8 27.4 % $ 485.8 34.7 % Other equity method investments 142.3 20%-50% 177.5 20%-50% $ 277.1 $ 663.3 (1) The fair value based on the closing price of the underlying equity security as of August 31, 2023, and February 28, 2023, was $97.8 million and $398.4 million, respectively. Canopy Equity Method Investment We have an investment in Canopy, a provider of medical and adult-use cannabis products. The Canopy Equity Method Investment consists of 171.5 million Canopy common shares. Equity in earnings (losses) from the Canopy Equity Method Investment and related activities is determined by recording the effect of basis differences. Amounts included in our consolidated results of operations for each period are as follows: For the Six Months For the Three Months 2023 2022 2023 2022 (in millions) Equity in earnings (losses) from Canopy and related activities $ (231.8) $ (815.7) $ (12.0) $ (650.7) Plan to convert Canopy common stock ownership In October 2022, we entered into a Consent Agreement with Canopy pursuant to which we have provided our consent, subject to certain conditions, to the Canopy Transaction. Canopy only holds non-voting and non-participating exchangeable shares of Canopy USA which are convertible into Class B shares of Canopy USA. A third-party investor holds 100% of the common shares of Canopy USA. In connection with the Canopy Transaction, Canopy has proposed to amend its share capital to (i) create Exchangeable Shares and (ii) restate the rights of Canopy common shares to provide for their conversion into Exchangeable Shares through the Canopy Amendment. Canopy has stated its intention to hold a special meeting of its shareholders to consider the Canopy Amendment. We have entered into a voting support agreement with Canopy to vote in favor of the Canopy Amendment. If the Canopy Transaction is completed and the Canopy Amendment is authorized by Canopy’s shareholders and adopted by Canopy, we intend, subject to a final decision in our sole discretion, to exercise our right to convert our Canopy common shares into Exchangeable Shares. Assuming the completion of the Canopy Transaction and the transactions contemplated by the Consent Agreement and that we elect to convert our Canopy common shares into Exchangeable Shares: • we intend to surrender our November 2018 Canopy Warrants to Canopy for cancellation; • we will only have an interest in Exchangeable Shares, which are non-voting and non-participating securities, and our 2023 Canopy Promissory Note (for which we intend to negotiate an exchange of the principal amount for Exchangeable Shares, although neither we nor Canopy has any binding obligation to do so); • we intend to terminate all legacy agreements and commercial arrangements between ourselves and Canopy, including the investor rights agreement but excluding the Consent Agreement and certain termination agreements; • we will have no further governance rights in relation to Canopy, including rights to nominate members to the board of directors of Canopy, or approval rights related to certain transactions; • all of our nominees will resign from the board of directors of Canopy; and • as our investment in Canopy common shares makes up our Canopy Equity Method Investment, we expect to no longer apply the equity method to our investment in Canopy, which we expect to instead be accounted for at fair value with changes reported in income (loss) from unconsolidated investments within our consolidated results. If we do not convert our Canopy common shares into Exchangeable Shares: • Canopy and its subsidiaries will not be permitted to exercise any rights to acquire shares and interests in entities carrying on cannabis-related business in the U.S.; • Canopy USA will be required to exercise its repurchase rights to acquire the interests in Canopy USA held by its third-party investors; and • we will continue to have all existing rights under our agreements with Canopy that predate the Consent Agreement, including governance rights in respect of Canopy (such as board nomination rights and approval rights in respect of certain transactions).

Borrowings

Borrowings	6 Months Ended
Borrowings	Aug. 31, 2023
Debt Disclosure [Abstract]
BORROWINGS	BORROWINGS Borrowings consist of the following: August 31, 2023 February 28, Current Long-term Total Total (in millions) Short-term borrowings Commercial paper $ 467.4 $ 1,165.3 $ 467.4 $ 1,165.3 Long-term debt Term loan credit facilities $ — $ — $ — $ 799.2 Senior notes 549.2 10,667.2 11,216.4 10,470.6 Other 9.1 13.6 22.7 26.2 $ 558.3 $ 10,680.8 $ 11,239.1 $ 11,296.0 Bank facilities The Company, CB International, the Administrative Agent, and certain other lenders are parties to the 2022 Credit Agreement. The Company, the Administrative Agent, and certain lenders were also parties to two term credit agreements. In May 2023, we repaid the outstanding three-year term loan facility borrowings under our August 2022 Term Credit Agreement with proceeds from the May 2023 Senior Notes (see “Senior notes” below). In August 2023, we repaid the outstanding five-year term loan facility borrowings under our April 2022 Term Credit Agreement with proceeds from commercial paper borrowings. In October 2022, the Company, CB International, the Administrative Agent, and certain other lenders agreed to amend the 2022 Credit Agreement. The October 2022 Credit Agreement Amendment revises certain defined terms and covenants and will become effective upon (i) the amendment by Canopy of its Articles of Incorporation, (ii) the conversion of our Canopy common shares into Exchangeable Shares, and (iii) the resignation of our nominees from the board of directors of Canopy. As of August 31, 2023, information with respect to borrowings under the 2022 Credit Agreement is as follows: Outstanding Interest SOFR Outstanding Remaining borrowing capacity (1) (in millions) 2022 Credit Agreement Revolving credit facility (2) (3) $ — — % — % $ 11.5 $ 1,770.5 (1) Net of outstanding revolving credit facility borrowings and outstanding letters of credit under the 2022 Credit Agreement and outstanding borrowings under our commercial paper program of $468.0 million (excluding unamortized discount) (see “Commercial paper program” below). (2) Contractual interest rate varies based on our debt rating (as defined in the agreement) and is a function of SOFR plus a margin and a credit spread adjustment, or the base rate plus a margin, or, in certain circumstances where SOFR cannot be adequately ascertained or available, an alternative benchmark rate plus a margin. (3) We and/or CB International are the borrower under the $2,250.0 million revolving credit facility with a maturity date of April 14, 2027. Includes a sub-facility for letters of credit of up to $200.0 million. We and our subsidiaries are subject to covenants that are contained in the 2022 Credit Agreement, including those restricting the incurrence of additional subsidiary indebtedness, additional liens, mergers and consolidations, transactions with affiliates, and sale and leaseback transactions, in each case subject to numerous conditions, exceptions, and thresholds. The financial covenants are limited to a minimum interest coverage ratio and a maximum net leverage ratio. Commercial paper program We have a commercial paper program which provides for the issuance of up to an aggregate principal amount of $2.25 billion of commercial paper. Our commercial paper program is backed by unused commitments under our revolving credit facility under our 2022 Credit Agreement. Accordingly, outstanding borrowings under our commercial paper program reduce the amount available under our revolving credit facility. As of August 31, 2023, we had $467.4 million of outstanding borrowings, net of unamortized discount, under our commercial paper program with a weighted average annual interest rate of 5.8% and a weighted average remaining term of nine days. Senior notes In May 2023, we issued $750.0 million aggregate principal amount of 4.90% senior notes due May 2033. Proceeds from this offering, net of discount and debt issuance costs, were $739.8 million. Interest on the 4.90% May 2023 Senior Notes is payable semiannually on May 1 and November 1 of each year, beginning November 1, 2023. The 4.90% May 2023 Senior Notes are redeemable, in whole or in part, at our option at any time prior to February 1, 2033, at a redemption price equal to 100% of the outstanding principal amount, plus accrued and unpaid interest and a make-whole payment based on the present value of the future payments at the adjusted treasury rate, as defined in the applicable indenture, plus 25 basis points. On or after February 1, 2033, we may redeem the 4.90% May 2023 Senior Notes, in whole or in part, at our option at any time at a redemption price equal to 100% of the outstanding principal amount, plus accrued and unpaid interest. The 4.90% May 2023 Senior Notes are senior unsecured obligations which rank equally in right of payment to all of our existing and future senior unsecured indebtedness. Debt payments As of August 31, 2023, the required principal repayments under long-term debt obligations (excluding unamortized debt issuance costs and unamortized discounts of $59.1 million and $24.5 million, respectively) for the remaining six months of Fiscal 2024 and for each of the five succeeding fiscal years and thereafter are as follows: (in millions) Fiscal 2024 $ 5.6 Fiscal 2025 956.6 Fiscal 2026 1,405.0 Fiscal 2027 603.8 Fiscal 2028 1,801.6 Fiscal 2029 500.0 Thereafter 6,050.1 $ 11,322.7

Income Taxes

Income Taxes	6 Months Ended
Income Taxes	Aug. 31, 2023
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES Our effective tax rate for the six months ended August 31, 2023, and August 31, 2022, was 22.1% and (53.3)%, respectively. Our effective tax rate for the three months ended August 31, 2023, and August 31, 2022, was 17.4% and (13.1)%, respectively. For the six months ended August 31, 2023, our effective tax rate was higher than the federal statutory rate of 21% primarily due to an increase in the valuation allowance related to our investment in Canopy, partially offset by (i) the benefit of lower effective tax rates applicable to our foreign businesses and (ii) a net income tax benefit recognized as a result of a change in tax entity classification. For the three months ended August 31, 2023, our effective tax rate was lower than the federal statutory rate of 21% primarily due to the benefit of lower effective tax rates applicable to our foreign businesses. For the six months and three months ended August 31, 2022, our effective tax rate did not approximate the federal statutory rate of 21% primarily due an increase in the valuation allowance related to our investment in Canopy, partially offset by a net income tax benefit recognized from the realization of tax losses related to a prior period divestiture.

Stockholders' Equity

Stockholders' Equity	6 Months Ended
Stockholders' Equity	Aug. 31, 2023
Equity [Abstract]
STOCKHOLDERS' EQUITY	STOCKHOLDERS’ EQUITY Common stock The number of shares of common stock issued and treasury stock, and associated share activity, are as follows: Common Stock Treasury Stock Class A Class B (1) Class 1 Class A Class B (1) Balance at February 28, 2023 212,697,428 — 22,705 29,498,426 — Share repurchases — — — 153,937 — Conversion of shares 80 — (80) — — Exercise of stock options — — 800 (129,595) — Vesting of restricted stock units (2) — — — (71,189) — Vesting of performance share units (2) — — — (13,113) — Balance at May 31, 2023 212,697,508 — 23,425 29,438,466 — Conversion of shares 220 — (220) — — Exercise of stock options — — 606 (364,530) — Employee stock purchases — — — (30,172) — Vesting of restricted stock units (2) — — — (5,172) — Balance at August 31, 2023 212,697,728 — 23,811 29,038,592 — Balance at February 28, 2022 187,263,859 28,212,340 2,248,679 22,824,607 5,005,800 Share repurchases — — — 4,065,508 — Conversion of shares 655 (655) — — — Exercise of stock options — — 35 (108,228) — Vesting of restricted stock units (2) — — — (71,064) — Vesting of performance share units (2) — — — (16,326) — Balance at May 31, 2022 187,264,514 28,211,685 2,248,714 26,694,497 5,005,800 Share repurchases — — — 1,652,445 — Conversion of shares 2,196,749 — (2,196,749) — — Exercise of stock options — — — (75,482) — Employee stock purchases — — — (27,514) — Vesting of restricted stock units (2) — — — (4,851) — Balance at August 31, 2022 189,461,263 28,211,685 51,965 28,239,095 5,005,800 (1) Prior to the Reclassification, we had an additional class of common stock with a material number of shares outstanding: Class B Stock. Shares of Class B Stock were convertible into shares of Class A Stock on a one-to-one basis at any time at the option of the holder. In November 2022, we completed the Reclassification at the Effective Time as contemplated by the Reclassification Agreement. Pursuant to the Reclassification, each share of Class B Stock issued and outstanding immediately prior to the Effective Time was reclassified, exchanged, and converted into one share of Class A Stock and the right to receive $64.64 in cash, without interest. The aggregate cash payment to holders of Class B Stock at the Effective Time was $1.5 billion. (2) Net of the following shares withheld to satisfy tax withholding requirements: For the Three For the Three For the Six 2023 Restricted Stock Units 39,839 170 40,009 Performance Share Units 8,735 — 8,735 2022 Restricted Stock Units 37,308 186 37,494 Performance Share Units 4,919 — 4,919 Stock repurchases In January 2021, our Board of Directors authorized the repurchase of up to $2.0 billion of our publicly traded common stock. The Board of Directors did not specify a date upon which this authorization would expire. Shares repurchased under the 2021 Authorization become treasury shares. For the six months ended August 31, 2023, we repurchased 153,937 shares of Class A Stock through open market transactions pursuant to this authorization at an aggregate cost of $35.0 million. As of August 31, 2023, total shares repurchased under this authorization are as follows: Class A Stock Repurchase Dollar Value Number of (in millions, except share data) 2021 Authorization $ 2,000.0 $ 1,171.6 4,985,847

Net Income (Loss) Per Common Sh

Net Income (Loss) Per Common Share Attributable to CBI	6 Months Ended
Net Income (Loss) Per Common Share Attributable to CBI	Aug. 31, 2023
Earnings Per Share [Abstract]
NET INCOME (LOSS) PER COMMON SHARE ATTRIBUTABLE TO CBI	NET INCOME (LOSS) PER COMMON SHARE ATTRIBUTABLE TO CBI For the six months and three months ended August 31, 2023, net income (loss) per common share – basic for Class A Stock has been computed based on the weighted average shares of common stock outstanding during the period. Net income (loss) per common share – diluted for Class A Stock reflects the weighted average shares of common stock plus the effect of dilutive securities outstanding during the period using the treasury stock method. The effect of dilutive securities includes the impact of outstanding stock-based awards. The dilutive computation does not assume conversion, exercise, or contingent issuance of securities that would have an anti-dilutive effect on the net income (loss) per common share attributable to CBI. The computation of basic and diluted net income (loss) per common share for Class A Stock are as follows: For the Six Months Ended August 31, 2023 For the Three Months Ended August 31, 2023 (in millions, except per share data) Net income (loss) attributable to CBI $ 825.9 $ 690.0 Weighted average common shares outstanding – basic 183.384 183.498 Stock-based awards, primarily stock options 0.690 0.779 Weighted average common shares outstanding – diluted 184.074 184.277 Net income (loss) per common share attributable to CBI – basic $ 4.50 $ 3.76 Net income (loss) per common share attributable to CBI – diluted $ 4.49 $ 3.74 For the six months and three months ended August 31, 2022, net income (loss) per common share – diluted for Class A Stock and Class B Stock has been computed using the two-class method. The computation of basic and diluted net income (loss) per common share are as follows: For the Six Months Ended August 31, 2022 For the Three Months Ended August 31, 2022 Class A Stock Class B Stock Class A Stock Class B Stock (in millions, except per share data) Net income (loss) attributable to CBI allocated – basic $ (674.2) $ (87.5) $ (1,018.2) $ (133.0) Conversion of Class B common shares into Class A common shares — — — — Effect of stock-based awards on allocated net income (loss) — — — — Net income (loss) attributable to CBI allocated – diluted $ (674.2) $ (87.5) $ (1,018.2) $ (133.0) Weighted average common shares outstanding – basic 163.532 23.206 161.730 23.206 Conversion of Class B common shares into Class A common shares — — — — Stock-based awards, primarily stock options (1) — — — — Weighted average common shares outstanding – diluted 163.532 23.206 161.730 23.206 Net income (loss) per common share attributable to CBI – basic $ (4.13) $ (3.77) $ (6.30) $ (5.73) Net income (loss) per common share attributable to CBI – diluted $ (4.13) $ (3.77) $ (6.30) $ (5.73) (1) We have excluded the following weighted average common shares outstanding from the calculation of diluted net income (loss) per common share, as the effect of including these would have been anti-dilutive: For the Six Months Ended August 31, 2022 For the Three Months Ended August 31, 2022 (in millions) Class B Stock 23.206 23.206 Stock-based awards, primarily stock options 0.802 0.801

Comprehensive Income (Loss) Att

Comprehensive Income (Loss) Attributable to CBI	6 Months Ended
Comprehensive Income (Loss) Attributable to CBI	Aug. 31, 2023
Equity [Abstract]
COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO CBI	COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO CBI Comprehensive income (loss) consists of net income (loss), foreign currency translation adjustments, unrealized net gain (loss) on derivative instruments, pension/postretirement adjustments, and our share of OCI of equity method investments. The reconciliation of net income (loss) attributable to CBI to comprehensive income (loss) attributable to CBI is as follows: Before Tax Tax (Expense) Net of Tax (in millions) For the Six Months Ended August 31, 2023 Net income (loss) attributable to CBI $ 825.9 Other comprehensive income (loss) attributable to CBI: Foreign currency translation adjustments: Net gain (loss) $ 323.6 $ — 323.6 Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) 323.6 — 323.6 Before Tax Tax (Expense) Net of Tax (in millions) Unrealized gain (loss) on cash flow hedges: Net derivative gain (loss) 162.8 (19.5) 143.3 Amounts reclassified (69.5) 8.0 (61.5) Net gain (loss) recognized in other comprehensive income (loss) 93.3 (11.5) 81.8 Pension/postretirement adjustments: Net actuarial gain (loss) (0.5) 0.1 (0.4) Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) (0.5) 0.1 (0.4) Share of OCI of equity method investments Net gain (loss) 0.8 0.1 0.9 Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) 0.8 0.1 0.9 Other comprehensive income (loss) attributable to CBI $ 417.2 $ (11.3) 405.9 Comprehensive income (loss) attributable to CBI $ 1,231.8 For the Six Months Ended August 31, 2022 Net income (loss) attributable to CBI $ (761.7) Other comprehensive income (loss) attributable to CBI: Foreign currency translation adjustments: Net gain (loss) $ (11.1) $ — (11.1) Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) (11.1) — (11.1) Unrealized gain (loss) on cash flow hedges: Net derivative gain (loss) 95.7 (13.1) 82.6 Amounts reclassified (20.3) 1.9 (18.4) Net gain (loss) recognized in other comprehensive income (loss) 75.4 (11.2) 64.2 Pension/postretirement adjustments: Net actuarial gain (loss) (0.2) 0.1 (0.1) Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) (0.2) 0.1 (0.1) Share of OCI of equity method investments Net gain (loss) 0.9 3.4 4.3 Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) 0.9 3.4 4.3 Other comprehensive income (loss) attributable to CBI $ 65.0 $ (7.7) 57.3 Comprehensive income (loss) attributable to CBI $ (704.4) Before Tax Tax (Expense) Net of Tax (in millions) For the Three Months Ended August 31, 2023 Net income (loss) attributable to CBI $ 690.0 Other comprehensive income (loss) attributable to CBI: Foreign currency translation adjustments: Net gain (loss) $ 160.2 $ — 160.2 Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) 160.2 — 160.2 Unrealized gain (loss) on cash flow hedges: Net derivative gain (loss) 76.4 (9.1) 67.3 Amounts reclassified (41.7) 4.8 (36.9) Net gain (loss) recognized in other comprehensive income (loss) 34.7 (4.3) 30.4 Pension/postretirement adjustments: Net actuarial gain (loss) (0.2) — (0.2) Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) (0.2) — (0.2) Share of OCI of equity method investments Net gain (loss) 1.1 — 1.1 Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) 1.1 — 1.1 Other comprehensive income (loss) attributable to CBI $ 195.8 $ (4.3) 191.5 Comprehensive income (loss) attributable to CBI $ 881.5 For the Three Months Ended August 31, 2022 Net income (loss) attributable to CBI $ (1,151.2) Other comprehensive income (loss) attributable to CBI: Foreign currency translation adjustments: Net gain (loss) $ (181.4) $ — (181.4) Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) (181.4) — (181.4) Unrealized gain (loss) on cash flow hedges: Net derivative gain (loss) (9.8) 1.7 (8.1) Amounts reclassified (10.3) 1.0 (9.3) Net gain (loss) recognized in other comprehensive income (loss) (20.1) 2.7 (17.4) Pension/postretirement adjustments: Net actuarial gain (loss) 0.1 0.1 0.2 Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) 0.1 0.1 0.2 Share of OCI of equity method investments Net gain (loss) 9.9 (0.4) 9.5 Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) 9.9 (0.4) 9.5 Other comprehensive income (loss) attributable to CBI $ (191.5) $ 2.4 (189.1) Comprehensive income (loss) attributable to CBI $ (1,340.3) Accumulated other comprehensive income (loss), net of income tax effect, includes the following components: Foreign Unrealized Net Pension/ Share of OCI Accumulated (in millions) Balance, February 28, 2023 $ (176.4) $ 198.5 $ (3.9) $ 10.3 $ 28.5 Other comprehensive income (loss): Other comprehensive income (loss) before reclassification adjustments 323.6 143.3 (0.4) 0.9 467.4 Amounts reclassified from accumulated other comprehensive income (loss) — (61.5) — — (61.5) Other comprehensive income (loss) 323.6 81.8 (0.4) 0.9 405.9 Balance, August 31, 2023 $ 147.2 $ 280.3 $ (4.3) $ 11.2 $ 434.4

Business Segment Information

Business Segment Information	6 Months Ended
Business Segment Information	Aug. 31, 2023
Segment Reporting [Abstract]
BUSINESS SEGMENT INFORMATION	BUSINESS SEGMENT INFORMATION Prior to May 31, 2023, our internal management financial reporting consisted of three business divisions: (i) Beer, (ii) Wine and Spirits, and (iii) Canopy and we reported our operating results in four segments: (i) Beer, (ii) Wine and Spirits, (iii) Corporate Operations and Other, and (iv) Canopy. Due to several factors occurring as of May 31, 2023, including those which led to the additional Canopy Equity Method Investment impairment combined with Canopy’s financial results no longer being provided to, or reviewed by, our CODM, and no longer being used to make strategic decisions, allocate resources, or assess performance, we have removed Canopy as a reportable segment. Accordingly, effective May 31, 2023, o ur internal management financial reporting consists of two business divisions: (i) Beer and (ii) Wine and Spirits and we report our operating results in three segments: (i) Beer, (ii) Wine and Spirits, and (iii) Corporate Operations and Other. In the Beer segment, our portfolio consists of high-end imported beer brands and ABAs. We have an exclusive perpetual brand license to import, market, and sell our Mexican beer portfolio in the U.S. In the Wine and Spirits segment, we sell a portfolio that includes higher-margin, higher-growth wine brands complemented by certain higher-end spirits brands. Amounts included in the Corporate Operations and Other segment consist of costs of executive management, corporate development, corporate finance, corporate growth and strategy, human resources, internal audit, investor relations, IT, legal, and public relations, as well as our Canopy investment and investments made through our corporate venture capital function . All costs included in the Corporate Operations and Other segment are general costs that are applicable to the consolidated group and are, therefore, not allocated to the other reportable segments. All costs reported within the Corporate Operations and Other segment are not included in our CODM’s evaluation of the operating income (loss) performance of the other reportable segments. The business segments reflect how our operations are managed, how resources are allocated, how operating performance is evaluated by senior management, and the structure of our internal financial reporting. Long-lived tangible assets and total asset information by segment is not provided to, or reviewed by, our CODM as it is not used to make strategic decisions, allocate resources, or assess performance. In addition, management excludes Comparable Adjustments from its evaluation of the results of each operating segment as these Comparable Adjustments are not reflective of core operations of the segments. Segment operating performance and the incentive compensation of segment management are evaluated based on core segment operating income (loss) which does not include the impact of these Comparable Adjustments. We evaluate segment operating performance based on operating income (loss) of the respective business units. Comparable Adjustments that impacted comparability in our segment operating income (loss) for each period are as follows: For the Six Months For the Three Months 2023 2022 2023 2022 (in millions) Cost of product sold Net gain (loss) on undesignated commodity derivative contracts $ (15.6) $ 33.1 $ 19.1 $ (15.4) Flow through of inventory step-up (1.5) (1.9) (0.8) (0.9) Settlements of undesignated commodity derivative contracts 6.2 (54.6) 5.6 (31.3) Net flow through of reserved inventory — 1.2 — 1.2 Recovery of (loss on) inventory write-down — 0.2 — — Comparable Adjustments, Cost of product sold (10.9) (22.0) 23.9 (46.4) Selling, general, and administrative expenses Restructuring and other strategic business development costs (18.3) (2.6) (3.4) (1.2) Transition services agreements activity (12.7) (7.9) (7.0) (4.5) Transaction, integration, and other acquisition-related costs (0.6) (0.7) (0.3) (0.5) Costs associated with the Reclassification 0.2 (21.3) — (20.6) Other gains (losses) (1) (9.3) 8.8 (2.3) 3.6 Comparable Adjustments, Selling, general, and administrative expenses (40.7) (23.7) (13.0) (23.2) Comparable Adjustments, Operating income (loss) $ (51.6) $ (45.7) $ 10.9 $ (69.6) (1) Primarily includes the following: For the Six Months For the Three Months 2023 2022 2023 2022 (in millions) Gain (loss) on sale of business $ (14.9) $ — $ (7.9) $ — Recognition of a previously deferred gain upon release of a related indemnity $ 5.6 $ — $ 5.6 $ — Gain from remeasurement of previously held equity method investments $ — $ 5.2 $ — $ — Decreases in estimated fair values of contingent liabilities associated with prior period acquisitions $ — $ 4.4 $ — $ 4.4 The accounting policies of the segments are the same as those described for the Company in Note 1 of our consolidated financial statements included in our 2023 Annual Report. Segment information is as follows: For the Six Months For the Three Months 2023 2022 2023 2022 (in millions) Beer Net sales $ 4,491.3 $ 4,037.5 $ 2,392.7 $ 2,139.3 Segment operating income (loss) $ 1,751.7 $ 1,628.4 $ 953.9 $ 865.6 Capital expenditures $ 440.3 $ 357.8 $ 234.7 $ 196.0 Depreciation and amortization $ 160.2 $ 135.2 $ 81.4 $ 67.0 For the Six Months For the Three Months 2023 2022 2023 2022 (in millions) Wine and Spirits Net sales: Wine $ 744.9 $ 846.1 $ 383.9 $ 442.0 Spirits 115.5 134.7 60.2 73.8 Net sales $ 860.4 $ 980.8 $ 444.1 $ 515.8 Segment operating income (loss) $ 160.0 $ 190.4 $ 80.7 $ 99.4 Income (loss) from unconsolidated investments $ 10.6 $ 4.9 $ 8.3 $ 3.4 Equity method investments $ 104.4 $ 100.5 $ 104.4 $ 100.5 Capital expenditures $ 77.5 $ 51.6 $ 38.9 $ 21.8 Depreciation and amortization $ 45.6 $ 43.3 $ 23.1 $ 21.0 Corporate Operations and Other Segment operating income (loss) $ (116.7) $ (143.6) $ (66.8) $ (82.3) Income (loss) from unconsolidated investments $ (54.4) $ (91.0) $ (21.1) $ (37.0) Equity method investments $ 172.7 $ 732.9 $ 172.7 $ 732.9 Capital expenditures $ 64.2 $ 25.6 $ 31.4 $ 20.6 Depreciation and amortization $ 8.6 $ 6.9 $ 4.2 $ 3.7 Comparable Adjustments Operating income (loss) $ (51.6) $ (45.7) $ 10.9 $ (69.6) Income (loss) from unconsolidated investments $ (391.8) $ (1,820.9) $ (7.4) $ (1,685.5) Consolidated Net sales $ 5,351.7 $ 5,018.3 $ 2,836.8 $ 2,655.1 Operating income (loss) $ 1,743.4 $ 1,629.5 $ 978.7 $ 813.1 Income (loss) from unconsolidated investments (1) $ (435.6) $ (1,907.0) $ (20.2) $ (1,719.1) Equity method investments $ 277.1 $ 833.4 $ 277.1 $ 833.4 Capital expenditures $ 582.0 $ 435.0 $ 305.0 $ 238.4 Depreciation and amortization $ 214.4 $ 185.4 $ 108.7 $ 91.7 (1) Income (loss) from unconsolidated investments consists of: For the Six Months For the Three Months 2023 2022 2023 2022 (in millions) Impairment of equity method investments $ (135.8) $ (1,060.3) $ (12.3) $ (1,060.3) Unrealized net gain (loss) on securities measured at fair value (74.4) (31.7) (2.6) (9.3) Equity in earnings (losses) from Canopy and related activities (231.8) (815.7) (12.0) (650.7) Equity in earnings (losses) from other equity method investees and related activities 6.4 0.7 6.7 1.2 $ (435.6) $ (1,907.0) $ (20.2) $ (1,719.1)

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended		6 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Millions	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022
Pay vs Performance Disclosure
Net income (loss) attributable to CBI	$ 690	$ (1,151.2)	$ 825.9	$ (761.7)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Aug. 31, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Basis of Presentation (Policies

Basis of Presentation (Policies)	6 Months Ended
Basis of Presentation (Policies)	Aug. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of presentation	We have prepared the Financial Statements, without audit, pursuant to the rules and regulations of the SEC applicable to quarterly reporting on Form 10-Q and reflect, in our opinion, all adjustments necessary to present fairly our financial information. All such adjustments are of a normal recurring nature. Certain information and footnote disclosures normally included in financial statements, prepared in accordance with generally accepted accounting principles, have been condensed or omitted as permitted by such rules and regulations. These Financial Statements should be read in conjunction with the consolidated financial statements and related notes included in the 2023 Annual Report. Results of operations for interim periods are not necessarily indicative of annual results. Effective May 31, 2023, we changed our internal management financial reporting to consist of two business divisions: (i) Beer and (ii) Wine and Spirits and we now report our operating results in three segments: (i) Beer, (ii) Wine and Spirits, and (iii) Corporate Operations and Other following the removal of the Canopy operating segment. All financial information for the six months and three months ended August 31, 2022, has been restated to conform to the new segment presentation. For additional information, refer to Note 13.

Inventories (Tables)

Inventories (Tables)	6 Months Ended
Inventories (Tables)	Aug. 31, 2023
Inventory Disclosure [Abstract]
Schedule of Components of Inventories	Elements of cost include materials, labor, and overhead and consist of the following: August 31, February 28, (in millions) Raw materials and supplies $ 226.4 $ 245.5 In-process inventories 930.2 967.8 Finished case goods 657.4 685.4 $ 1,814.0 $ 1,898.7

Derivative Instruments (Tables)

Derivative Instruments (Tables)	6 Months Ended
Derivative Instruments (Tables)	Aug. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Aggregate notional value of outstanding derivative instruments	The aggregate notional value of outstanding derivative instruments is as follows: August 31, February 28, (in millions) Derivative instruments designated as hedging instruments Foreign currency contracts $ 1,904.9 $ 1,969.5 Derivative instruments not designated as hedging instruments Foreign currency contracts $ 810.9 $ 831.7 Commodity derivative contracts $ 344.6 $ 416.5
Fair value and location of derivative instruments on our balance sheets	The estimated fair value and location of our derivative instruments on our balance sheets are as follows (see Note 4): Assets Liabilities August 31, February 28, August 31, February 28, (in millions) Derivative instruments designated as hedging instruments Foreign currency contracts: Prepaid expenses and other $ 156.0 $ 109.1 Other accrued expenses and liabilities $ 7.6 $ 9.8 Other assets $ 173.8 $ 134.5 Deferred income taxes and other liabilities $ 2.0 $ 3.5 Derivative instruments not designated as hedging instruments Foreign currency contracts: Prepaid expenses and other $ 5.0 $ 5.9 Other accrued expenses and liabilities $ 2.7 $ 3.9 Commodity derivative contracts: Prepaid expenses and other $ 14.6 $ 21.2 Other accrued expenses and liabilities $ 22.2 $ 19.5 Other assets $ 3.3 $ 4.6 Deferred income taxes and other liabilities $ 6.2 $ 8.3
Effect of derivative instruments on our results of operations and OCI	The principal effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, as well as OCI, net of income tax effect, is as follows: Derivative Instruments in Net Location of Net Gain (Loss) Net (in millions) For the Six Months Ended August 31, 2023 Foreign currency contracts $ 149.9 Sales $ (0.2) Cost of product sold 65.7 Pre-issuance hedge contracts 0.6 Interest expense (0.3) $ 150.5 $ 65.2 For the Six Months Ended August 31, 2022 Foreign currency contracts $ 71.3 Sales $ (1.2) Cost of product sold 21.9 Pre-issuance hedge contracts 15.7 Interest expense (0.6) $ 87.0 $ 20.1 For the Three Months Ended August 31, 2023 Foreign currency contracts $ 70.6 Sales $ (0.2) Cost of product sold 39.3 Pre-issuance hedge contracts — Interest expense (0.1) $ 70.6 $ 39.0 For the Three Months Ended August 31, 2022 Foreign currency contracts $ (8.2) Sales $ (0.6) Cost of product sold 10.8 Pre-issuance hedge contracts — Interest expense (0.1) $ (8.2) $ 10.1 The effect of our undesignated derivative instruments on our results of operations is as follows: Derivative Instruments Not Location of Net Gain (Loss) Net (in millions) For the Six Months Ended August 31, 2023 Commodity derivative contracts Cost of product sold $ (15.6) Foreign currency contracts Selling, general, and administrative expenses 22.5 $ 6.9 Derivative Instruments Not Location of Net Gain (Loss) Net (in millions) For the Six Months Ended August 31, 2022 Commodity derivative contracts Cost of product sold $ 33.1 Foreign currency contracts Selling, general, and administrative expenses (2.6) $ 30.5 For the Three Months Ended August 31, 2023 Commodity derivative contracts Cost of product sold $ 19.1 Foreign currency contracts Selling, general, and administrative expenses 9.8 $ 28.9 For the Three Months Ended August 31, 2022 Commodity derivative contracts Cost of product sold $ (15.4) Foreign currency contracts Selling, general, and administrative expenses (8.8) $ (24.2)

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	6 Months Ended
Fair Value of Financial Instruments (Tables)	Aug. 31, 2023
Fair Value Disclosures [Abstract]
Financial assets and liabilities measured at estimated fair value on a recurring basis	The following table presents our financial assets and liabilities measured at estimated fair value on a recurring basis: Fair Value Measurements Using Quoted Significant Significant Total (in millions) August 31, 2023 Assets: Foreign currency contracts $ — $ 334.8 $ — $ 334.8 Commodity derivative contracts $ — $ 17.9 $ — $ 17.9 Liabilities: Foreign currency contracts $ — $ 12.3 $ — $ 12.3 Commodity derivative contracts $ — $ 28.4 $ — $ 28.4 Fair Value Measurements Using Quoted Significant Significant Total (in millions) February 28, 2023 Assets: Foreign currency contracts $ — $ 249.5 $ — $ 249.5 Commodity derivative contracts $ — $ 25.8 $ — $ 25.8 November 2018 Canopy Warrants $ — $ 0.2 $ — $ 0.2 Canopy Debt Securities $ — $ 69.6 $ — $ 69.6 Liabilities: Foreign currency contracts $ — $ 17.2 $ — $ 17.2 Commodity derivative contracts $ — $ 27.8 $ — $ 27.8
Assets and liabilities measured at estimated fair value on a nonrecurring basis	The following table presents our assets and liabilities measured at estimated fair value on a nonrecurring basis for which an impairment assessment was performed for the periods presented: Fair Value Measurements Using Quoted Significant Significant Total Losses (in millions) For the Six Months Ended August 31, 2023 Equity method investments (1) $ 97.8 $ 2.6 $ — $ 135.8 For the Six Months Ended August 31, 2022 Equity method investments $ 634.8 $ — $ — $ 1,060.3 (1) As of August 31, 2023, the carrying value of the Canopy Equity Method Investment exceeded the fair value (Level 1 fair value measurement). We evaluated and determined there was not an other-than-temporary impairment. Our conclusion was based primarily on the period of time for which the fair value had been less than the carrying value, including Canopy’s stock price recovery above our carrying value following quarter-end. We will continue to evaluate the Canopy Equity Method Investment for an other-than-temporary impairment.

Goodwill (Tables)

Goodwill (Tables)	6 Months Ended
Goodwill (Tables)	Aug. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Changes in the carrying amount of goodwill	The changes in the carrying amount of goodwill are as follows: Beer Wine and Spirits Consolidated (in millions) Balance, February 28, 2022 $ 5,120.7 $ 2,741.7 $ 7,862.4 Purchase accounting allocations (1) — 26.3 26.3 Wine Divestiture — (24.5) (24.5) Foreign currency translation adjustments 68.2 (7.0) 61.2 Balance, February 28, 2023 5,188.9 2,736.5 7,925.4 Purchase accounting allocations (2) — 4.2 4.2 Foreign currency translation adjustments 58.1 (2.1) 56.0 Balance, August 31, 2023 $ 5,247.0 $ 2,738.6 $ 7,985.6 (1) Purchase accounting allocations associated with the acquisitions of Austin Cocktails, Lingua Franca, and My Favorite Neighbor, LLC. (2) Preliminary purchase accounting allocation associated with the June 2023 acquisition of the Domaine Curry wine brand.

Intangible Assets (Tables)

Intangible Assets (Tables)	6 Months Ended
Intangible Assets (Tables)	Aug. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Major components of intangible assets, Amortizable intangible assets	The major components of intangible assets are as follows: August 31, 2023 February 28, 2023 Gross Net Gross Net (in millions) Amortizable intangible assets Customer relationships $ 85.3 $ 16.8 $ 85.7 $ 17.7 Other 20.4 — 20.8 — Total $ 105.7 16.8 $ 106.5 17.7 Nonamortizable intangible assets Trademarks 2,717.7 2,710.4 Total intangible assets $ 2,734.5 $ 2,728.1
Major components of intangible assets, Nonamortizable intangible assets	The major components of intangible assets are as follows: August 31, 2023 February 28, 2023 Gross Net Gross Net (in millions) Amortizable intangible assets Customer relationships $ 85.3 $ 16.8 $ 85.7 $ 17.7 Other 20.4 — 20.8 — Total $ 105.7 16.8 $ 106.5 17.7 Nonamortizable intangible assets Trademarks 2,717.7 2,710.4 Total intangible assets $ 2,734.5 $ 2,728.1

Equity Method Investments (Tabl

Equity Method Investments (Tables)	6 Months Ended
Equity Method Investments (Tables)	Aug. 31, 2023
Equity Method Investments and Joint Ventures [Abstract]
Equity method investments	Our equity method investments are as follows: August 31, 2023 February 28, 2023 Carrying Value Ownership Percentage Carrying Value Ownership Percentage (in millions) Canopy Equity Method Investment (1) $ 134.8 27.4 % $ 485.8 34.7 % Other equity method investments 142.3 20%-50% 177.5 20%-50% $ 277.1 $ 663.3 (1) The fair value based on the closing price of the underlying equity security as of August 31, 2023, and February 28, 2023, was $97.8 million and $398.4 million, respectively. For the Six Months For the Three Months 2023 2022 2023 2022 (in millions) Equity in earnings (losses) from Canopy and related activities $ (231.8) $ (815.7) $ (12.0) $ (650.7)

Borrowings (Tables)

Borrowings (Tables)	6 Months Ended
Borrowings (Tables)	Aug. 31, 2023
Debt Disclosure [Abstract]
Borrowings	Borrowings consist of the following: August 31, 2023 February 28, Current Long-term Total Total (in millions) Short-term borrowings Commercial paper $ 467.4 $ 1,165.3 $ 467.4 $ 1,165.3 Long-term debt Term loan credit facilities $ — $ — $ — $ 799.2 Senior notes 549.2 10,667.2 11,216.4 10,470.6 Other 9.1 13.6 22.7 26.2 $ 558.3 $ 10,680.8 $ 11,239.1 $ 11,296.0 As of August 31, 2023, information with respect to borrowings under the 2022 Credit Agreement is as follows: Outstanding Interest SOFR Outstanding Remaining borrowing capacity (1) (in millions) 2022 Credit Agreement Revolving credit facility (2) (3) $ — — % — % $ 11.5 $ 1,770.5 (1) Net of outstanding revolving credit facility borrowings and outstanding letters of credit under the 2022 Credit Agreement and outstanding borrowings under our commercial paper program of $468.0 million (excluding unamortized discount) (see “Commercial paper program” below). (2) Contractual interest rate varies based on our debt rating (as defined in the agreement) and is a function of SOFR plus a margin and a credit spread adjustment, or the base rate plus a margin, or, in certain circumstances where SOFR cannot be adequately ascertained or available, an alternative benchmark rate plus a margin. (3) We and/or CB International are the borrower under the $2,250.0 million revolving credit facility with a maturity date of April 14, 2027. Includes a sub-facility for letters of credit of up to $200.0 million.
Schedule of maturities of long-term debt	As of August 31, 2023, the required principal repayments under long-term debt obligations (excluding unamortized debt issuance costs and unamortized discounts of $59.1 million and $24.5 million, respectively) for the remaining six months of Fiscal 2024 and for each of the five succeeding fiscal years and thereafter are as follows: (in millions) Fiscal 2024 $ 5.6 Fiscal 2025 956.6 Fiscal 2026 1,405.0 Fiscal 2027 603.8 Fiscal 2028 1,801.6 Fiscal 2029 500.0 Thereafter 6,050.1 $ 11,322.7

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	6 Months Ended
Stockholders' Equity (Tables)	Aug. 31, 2023
Equity [Abstract]
Number of shares of common stock issued and treasury stock, and associated share activity	The number of shares of common stock issued and treasury stock, and associated share activity, are as follows: Common Stock Treasury Stock Class A Class B (1) Class 1 Class A Class B (1) Balance at February 28, 2023 212,697,428 — 22,705 29,498,426 — Share repurchases — — — 153,937 — Conversion of shares 80 — (80) — — Exercise of stock options — — 800 (129,595) — Vesting of restricted stock units (2) — — — (71,189) — Vesting of performance share units (2) — — — (13,113) — Balance at May 31, 2023 212,697,508 — 23,425 29,438,466 — Conversion of shares 220 — (220) — — Exercise of stock options — — 606 (364,530) — Employee stock purchases — — — (30,172) — Vesting of restricted stock units (2) — — — (5,172) — Balance at August 31, 2023 212,697,728 — 23,811 29,038,592 — Balance at February 28, 2022 187,263,859 28,212,340 2,248,679 22,824,607 5,005,800 Share repurchases — — — 4,065,508 — Conversion of shares 655 (655) — — — Exercise of stock options — — 35 (108,228) — Vesting of restricted stock units (2) — — — (71,064) — Vesting of performance share units (2) — — — (16,326) — Balance at May 31, 2022 187,264,514 28,211,685 2,248,714 26,694,497 5,005,800 Share repurchases — — — 1,652,445 — Conversion of shares 2,196,749 — (2,196,749) — — Exercise of stock options — — — (75,482) — Employee stock purchases — — — (27,514) — Vesting of restricted stock units (2) — — — (4,851) — Balance at August 31, 2022 189,461,263 28,211,685 51,965 28,239,095 5,005,800 (1) Prior to the Reclassification, we had an additional class of common stock with a material number of shares outstanding: Class B Stock. Shares of Class B Stock were convertible into shares of Class A Stock on a one-to-one basis at any time at the option of the holder. In November 2022, we completed the Reclassification at the Effective Time as contemplated by the Reclassification Agreement. Pursuant to the Reclassification, each share of Class B Stock issued and outstanding immediately prior to the Effective Time was reclassified, exchanged, and converted into one share of Class A Stock and the right to receive $64.64 in cash, without interest. The aggregate cash payment to holders of Class B Stock at the Effective Time was $1.5 billion. (2) Net of the following shares withheld to satisfy tax withholding requirements: For the Three For the Three For the Six 2023 Restricted Stock Units 39,839 170 40,009 Performance Share Units 8,735 — 8,735 2022 Restricted Stock Units 37,308 186 37,494 Performance Share Units 4,919 — 4,919
Summary of share repurchase activity	As of August 31, 2023, total shares repurchased under this authorization are as follows: Class A Stock Repurchase Dollar Value Number of (in millions, except share data) 2021 Authorization $ 2,000.0 $ 1,171.6 4,985,847

Net Income (Loss) Per Common _2

Net Income (Loss) Per Common Share Attributable to CBI (Tables)	6 Months Ended
	Aug. 31, 2023
Earnings Per Share [Abstract]
Basic and diluted net income (loss) per common share attributable to CBI	The computation of basic and diluted net income (loss) per common share for Class A Stock are as follows: For the Six Months Ended August 31, 2023 For the Three Months Ended August 31, 2023 (in millions, except per share data) Net income (loss) attributable to CBI $ 825.9 $ 690.0 Weighted average common shares outstanding – basic 183.384 183.498 Stock-based awards, primarily stock options 0.690 0.779 Weighted average common shares outstanding – diluted 184.074 184.277 Net income (loss) per common share attributable to CBI – basic $ 4.50 $ 3.76 Net income (loss) per common share attributable to CBI – diluted $ 4.49 $ 3.74 For the six months and three months ended August 31, 2022, net income (loss) per common share – diluted for Class A Stock and Class B Stock has been computed using the two-class method. The computation of basic and diluted net income (loss) per common share are as follows: For the Six Months Ended August 31, 2022 For the Three Months Ended August 31, 2022 Class A Stock Class B Stock Class A Stock Class B Stock (in millions, except per share data) Net income (loss) attributable to CBI allocated – basic $ (674.2) $ (87.5) $ (1,018.2) $ (133.0) Conversion of Class B common shares into Class A common shares — — — — Effect of stock-based awards on allocated net income (loss) — — — — Net income (loss) attributable to CBI allocated – diluted $ (674.2) $ (87.5) $ (1,018.2) $ (133.0) Weighted average common shares outstanding – basic 163.532 23.206 161.730 23.206 Conversion of Class B common shares into Class A common shares — — — — Stock-based awards, primarily stock options (1) — — — — Weighted average common shares outstanding – diluted 163.532 23.206 161.730 23.206 Net income (loss) per common share attributable to CBI – basic $ (4.13) $ (3.77) $ (6.30) $ (5.73) Net income (loss) per common share attributable to CBI – diluted $ (4.13) $ (3.77) $ (6.30) $ (5.73) (1) We have excluded the following weighted average common shares outstanding from the calculation of diluted net income (loss) per common share, as the effect of including these would have been anti-dilutive: For the Six Months Ended August 31, 2022 For the Three Months Ended August 31, 2022 (in millions) Class B Stock 23.206 23.206 Stock-based awards, primarily stock options 0.802 0.801

Comprehensive Income (Loss) A_2

Comprehensive Income (Loss) Attributable to CBI (Tables)	6 Months Ended
Comprehensive Income (Loss) Attributable to CBI (Tables)	Aug. 31, 2023
Equity [Abstract]
Reconciliation of net income (loss) attributable to CBI to comprehensive income (loss) attributable to CBI	The reconciliation of net income (loss) attributable to CBI to comprehensive income (loss) attributable to CBI is as follows: Before Tax Tax (Expense) Net of Tax (in millions) For the Six Months Ended August 31, 2023 Net income (loss) attributable to CBI $ 825.9 Other comprehensive income (loss) attributable to CBI: Foreign currency translation adjustments: Net gain (loss) $ 323.6 $ — 323.6 Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) 323.6 — 323.6 Before Tax Tax (Expense) Net of Tax (in millions) Unrealized gain (loss) on cash flow hedges: Net derivative gain (loss) 162.8 (19.5) 143.3 Amounts reclassified (69.5) 8.0 (61.5) Net gain (loss) recognized in other comprehensive income (loss) 93.3 (11.5) 81.8 Pension/postretirement adjustments: Net actuarial gain (loss) (0.5) 0.1 (0.4) Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) (0.5) 0.1 (0.4) Share of OCI of equity method investments Net gain (loss) 0.8 0.1 0.9 Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) 0.8 0.1 0.9 Other comprehensive income (loss) attributable to CBI $ 417.2 $ (11.3) 405.9 Comprehensive income (loss) attributable to CBI $ 1,231.8 For the Six Months Ended August 31, 2022 Net income (loss) attributable to CBI $ (761.7) Other comprehensive income (loss) attributable to CBI: Foreign currency translation adjustments: Net gain (loss) $ (11.1) $ — (11.1) Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) (11.1) — (11.1) Unrealized gain (loss) on cash flow hedges: Net derivative gain (loss) 95.7 (13.1) 82.6 Amounts reclassified (20.3) 1.9 (18.4) Net gain (loss) recognized in other comprehensive income (loss) 75.4 (11.2) 64.2 Pension/postretirement adjustments: Net actuarial gain (loss) (0.2) 0.1 (0.1) Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) (0.2) 0.1 (0.1) Share of OCI of equity method investments Net gain (loss) 0.9 3.4 4.3 Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) 0.9 3.4 4.3 Other comprehensive income (loss) attributable to CBI $ 65.0 $ (7.7) 57.3 Comprehensive income (loss) attributable to CBI $ (704.4) Before Tax Tax (Expense) Net of Tax (in millions) For the Three Months Ended August 31, 2023 Net income (loss) attributable to CBI $ 690.0 Other comprehensive income (loss) attributable to CBI: Foreign currency translation adjustments: Net gain (loss) $ 160.2 $ — 160.2 Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) 160.2 — 160.2 Unrealized gain (loss) on cash flow hedges: Net derivative gain (loss) 76.4 (9.1) 67.3 Amounts reclassified (41.7) 4.8 (36.9) Net gain (loss) recognized in other comprehensive income (loss) 34.7 (4.3) 30.4 Pension/postretirement adjustments: Net actuarial gain (loss) (0.2) — (0.2) Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) (0.2) — (0.2) Share of OCI of equity method investments Net gain (loss) 1.1 — 1.1 Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) 1.1 — 1.1 Other comprehensive income (loss) attributable to CBI $ 195.8 $ (4.3) 191.5 Comprehensive income (loss) attributable to CBI $ 881.5 For the Three Months Ended August 31, 2022 Net income (loss) attributable to CBI $ (1,151.2) Other comprehensive income (loss) attributable to CBI: Foreign currency translation adjustments: Net gain (loss) $ (181.4) $ — (181.4) Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) (181.4) — (181.4) Unrealized gain (loss) on cash flow hedges: Net derivative gain (loss) (9.8) 1.7 (8.1) Amounts reclassified (10.3) 1.0 (9.3) Net gain (loss) recognized in other comprehensive income (loss) (20.1) 2.7 (17.4) Pension/postretirement adjustments: Net actuarial gain (loss) 0.1 0.1 0.2 Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) 0.1 0.1 0.2 Share of OCI of equity method investments Net gain (loss) 9.9 (0.4) 9.5 Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) 9.9 (0.4) 9.5 Other comprehensive income (loss) attributable to CBI $ (191.5) $ 2.4 (189.1) Comprehensive income (loss) attributable to CBI $ (1,340.3)
Accumulated other comprehensive income (loss), net of income tax effect	Accumulated other comprehensive income (loss), net of income tax effect, includes the following components: Foreign Unrealized Net Pension/ Share of OCI Accumulated (in millions) Balance, February 28, 2023 $ (176.4) $ 198.5 $ (3.9) $ 10.3 $ 28.5 Other comprehensive income (loss): Other comprehensive income (loss) before reclassification adjustments 323.6 143.3 (0.4) 0.9 467.4 Amounts reclassified from accumulated other comprehensive income (loss) — (61.5) — — (61.5) Other comprehensive income (loss) 323.6 81.8 (0.4) 0.9 405.9 Balance, August 31, 2023 $ 147.2 $ 280.3 $ (4.3) $ 11.2 $ 434.4

Business Segment Information (T

Business Segment Information (Tables)	6 Months Ended
Business Segment Information (Tables)	Aug. 31, 2023
Segment Reporting [Abstract]
Comparable adjustments	Comparable Adjustments that impacted comparability in our segment operating income (loss) for each period are as follows: For the Six Months For the Three Months 2023 2022 2023 2022 (in millions) Cost of product sold Net gain (loss) on undesignated commodity derivative contracts $ (15.6) $ 33.1 $ 19.1 $ (15.4) Flow through of inventory step-up (1.5) (1.9) (0.8) (0.9) Settlements of undesignated commodity derivative contracts 6.2 (54.6) 5.6 (31.3) Net flow through of reserved inventory — 1.2 — 1.2 Recovery of (loss on) inventory write-down — 0.2 — — Comparable Adjustments, Cost of product sold (10.9) (22.0) 23.9 (46.4) Selling, general, and administrative expenses Restructuring and other strategic business development costs (18.3) (2.6) (3.4) (1.2) Transition services agreements activity (12.7) (7.9) (7.0) (4.5) Transaction, integration, and other acquisition-related costs (0.6) (0.7) (0.3) (0.5) Costs associated with the Reclassification 0.2 (21.3) — (20.6) Other gains (losses) (1) (9.3) 8.8 (2.3) 3.6 Comparable Adjustments, Selling, general, and administrative expenses (40.7) (23.7) (13.0) (23.2) Comparable Adjustments, Operating income (loss) $ (51.6) $ (45.7) $ 10.9 $ (69.6) (1) Primarily includes the following: For the Six Months For the Three Months 2023 2022 2023 2022 (in millions) Gain (loss) on sale of business $ (14.9) $ — $ (7.9) $ — Recognition of a previously deferred gain upon release of a related indemnity $ 5.6 $ — $ 5.6 $ — Gain from remeasurement of previously held equity method investments $ — $ 5.2 $ — $ — Decreases in estimated fair values of contingent liabilities associated with prior period acquisitions $ — $ 4.4 $ — $ 4.4
Segment information	Segment information is as follows: For the Six Months For the Three Months 2023 2022 2023 2022 (in millions) Beer Net sales $ 4,491.3 $ 4,037.5 $ 2,392.7 $ 2,139.3 Segment operating income (loss) $ 1,751.7 $ 1,628.4 $ 953.9 $ 865.6 Capital expenditures $ 440.3 $ 357.8 $ 234.7 $ 196.0 Depreciation and amortization $ 160.2 $ 135.2 $ 81.4 $ 67.0 For the Six Months For the Three Months 2023 2022 2023 2022 (in millions) Wine and Spirits Net sales: Wine $ 744.9 $ 846.1 $ 383.9 $ 442.0 Spirits 115.5 134.7 60.2 73.8 Net sales $ 860.4 $ 980.8 $ 444.1 $ 515.8 Segment operating income (loss) $ 160.0 $ 190.4 $ 80.7 $ 99.4 Income (loss) from unconsolidated investments $ 10.6 $ 4.9 $ 8.3 $ 3.4 Equity method investments $ 104.4 $ 100.5 $ 104.4 $ 100.5 Capital expenditures $ 77.5 $ 51.6 $ 38.9 $ 21.8 Depreciation and amortization $ 45.6 $ 43.3 $ 23.1 $ 21.0 Corporate Operations and Other Segment operating income (loss) $ (116.7) $ (143.6) $ (66.8) $ (82.3) Income (loss) from unconsolidated investments $ (54.4) $ (91.0) $ (21.1) $ (37.0) Equity method investments $ 172.7 $ 732.9 $ 172.7 $ 732.9 Capital expenditures $ 64.2 $ 25.6 $ 31.4 $ 20.6 Depreciation and amortization $ 8.6 $ 6.9 $ 4.2 $ 3.7 Comparable Adjustments Operating income (loss) $ (51.6) $ (45.7) $ 10.9 $ (69.6) Income (loss) from unconsolidated investments $ (391.8) $ (1,820.9) $ (7.4) $ (1,685.5) Consolidated Net sales $ 5,351.7 $ 5,018.3 $ 2,836.8 $ 2,655.1 Operating income (loss) $ 1,743.4 $ 1,629.5 $ 978.7 $ 813.1 Income (loss) from unconsolidated investments (1) $ (435.6) $ (1,907.0) $ (20.2) $ (1,719.1) Equity method investments $ 277.1 $ 833.4 $ 277.1 $ 833.4 Capital expenditures $ 582.0 $ 435.0 $ 305.0 $ 238.4 Depreciation and amortization $ 214.4 $ 185.4 $ 108.7 $ 91.7 (1) Income (loss) from unconsolidated investments consists of: For the Six Months For the Three Months 2023 2022 2023 2022 (in millions) Impairment of equity method investments $ (135.8) $ (1,060.3) $ (12.3) $ (1,060.3) Unrealized net gain (loss) on securities measured at fair value (74.4) (31.7) (2.6) (9.3) Equity in earnings (losses) from Canopy and related activities (231.8) (815.7) (12.0) (650.7) Equity in earnings (losses) from other equity method investees and related activities 6.4 0.7 6.7 1.2 $ (435.6) $ (1,907.0) $ (20.2) $ (1,719.1)

Basis of Presentation - Narrati

Basis of Presentation - Narrative (Details)	3 Months Ended	6 Months Ended
Basis of Presentation - Narrative (Details)	May 31, 2023 division segment	Aug. 31, 2023 segment division
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of business divisions \| division	3	2
Number of reportable operating segments \| segment	4	3

Inventories - Schedule of Costs

Inventories - Schedule of Costs of Inventory (Details) - USD ($) $ in Millions	Aug. 31, 2023	Feb. 28, 2023
Inventory Disclosure [Abstract]
Raw materials and supplies	$ 226.4	$ 245.5
In-process inventories	930.2	967.8
Finished case goods	657.4	685.4
Inventories, Total	$ 1,814	$ 1,898.7

Derivative Instruments - Aggreg

Derivative Instruments - Aggregate Notional Value of Outstanding Derivative Instruments (Details) - USD ($) $ in Millions	Aug. 31, 2023	Feb. 28, 2023
Derivative instruments designated as hedging instruments \| Foreign currency contracts
Derivative [Line Items]
Aggregate notional value of derivative instruments	$ 1,904.9	$ 1,969.5
Derivative instruments not designated as hedging instruments \| Foreign currency contracts
Derivative [Line Items]
Aggregate notional value of derivative instruments	810.9	831.7
Derivative instruments not designated as hedging instruments \| Commodity derivative contracts
Derivative [Line Items]
Aggregate notional value of derivative instruments	$ 344.6	$ 416.5

Derivative Instruments - Narrat

Derivative Instruments - Narrative (Details) $ in Millions	6 Months Ended
Derivative Instruments - Narrative (Details) $ in Millions	Aug. 31, 2023 USD ($)
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Fair value of derivative instruments in a net liability position due to counterparties	$ 1.7
Amount of net gains (losses), net of income tax effect, to be reclassified from AOCI to our results of operations within the next 12 months	$ 130.3

Derivative Instruments - Estima

Derivative Instruments - Estimated Fair Value and Location of Derivative Instruments (Details) - USD ($) $ in Millions	Aug. 31, 2023	Feb. 28, 2023
Derivative instruments designated as hedging instruments \| Foreign currency contracts \| Prepaid expenses and other
Fair value and location of our derivative instruments on our balance sheets
Foreign currency contracts, Assets	$ 156	$ 109.1
Derivative instruments designated as hedging instruments \| Foreign currency contracts \| Other accrued expenses and liabilities
Fair value and location of our derivative instruments on our balance sheets
Foreign currency contracts, Liabilities	7.6	9.8
Derivative instruments designated as hedging instruments \| Foreign currency contracts \| Other assets
Fair value and location of our derivative instruments on our balance sheets
Foreign currency contracts, Assets	173.8	134.5
Derivative instruments designated as hedging instruments \| Foreign currency contracts \| Deferred income taxes and other liabilities
Fair value and location of our derivative instruments on our balance sheets
Foreign currency contracts, Liabilities	2	3.5
Derivative instruments not designated as hedging instruments \| Foreign currency contracts \| Prepaid expenses and other
Fair value and location of our derivative instruments on our balance sheets
Foreign currency contracts, Assets	5	5.9
Derivative instruments not designated as hedging instruments \| Foreign currency contracts \| Other accrued expenses and liabilities
Fair value and location of our derivative instruments on our balance sheets
Foreign currency contracts, Liabilities	2.7	3.9
Derivative instruments not designated as hedging instruments \| Commodity derivative contracts \| Prepaid expenses and other
Fair value and location of our derivative instruments on our balance sheets
Commodity derivative contracts, Assets	14.6	21.2
Derivative instruments not designated as hedging instruments \| Commodity derivative contracts \| Other accrued expenses and liabilities
Fair value and location of our derivative instruments on our balance sheets
Commodity derivative contracts, Liabilities	22.2	19.5
Derivative instruments not designated as hedging instruments \| Commodity derivative contracts \| Other assets
Fair value and location of our derivative instruments on our balance sheets
Commodity derivative contracts, Assets	3.3	4.6
Derivative instruments not designated as hedging instruments \| Commodity derivative contracts \| Deferred income taxes and other liabilities
Fair value and location of our derivative instruments on our balance sheets
Commodity derivative contracts, Liabilities	$ 6.2	$ 8.3

Derivative Instruments - Effect

Derivative Instruments - Effects of Designated and Undesignated Hedging Instruments (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022
Effect of our undesignated derivative instruments on our results of operations
Net Gain (Loss) Recognized in Income (Loss)	$ 28.9	$ (24.2)	$ 6.9	$ 30.5
Foreign currency contracts \| Selling, general, and administrative expenses
Effect of our undesignated derivative instruments on our results of operations
Net Gain (Loss) Recognized in Income (Loss)	9.8	(8.8)	22.5	(2.6)
Commodity derivative contracts \| Cost of product sold
Effect of our undesignated derivative instruments on our results of operations
Net Gain (Loss) Recognized in Income (Loss)	19.1	(15.4)	(15.6)	33.1
Cash flow hedging
Effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, net of income tax effect
Net Gain (Loss) Recognized in OCI	70.6	(8.2)	150.5	87
Net Gain (Loss) Reclassified from AOCI to Income (Loss)	39	10.1	65.2	20.1
Cash flow hedging \| Foreign currency contracts
Effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, net of income tax effect
Net Gain (Loss) Recognized in OCI	70.6	(8.2)	149.9	71.3
Cash flow hedging \| Foreign currency contracts \| Sales
Effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, net of income tax effect
Net Gain (Loss) Reclassified from AOCI to Income (Loss)	(0.2)	(0.6)	(0.2)	(1.2)
Cash flow hedging \| Foreign currency contracts \| Cost of product sold
Effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, net of income tax effect
Net Gain (Loss) Reclassified from AOCI to Income (Loss)	39.3	10.8	65.7	21.9
Cash flow hedging \| Pre-issuance hedge contracts
Effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, net of income tax effect
Net Gain (Loss) Recognized in OCI	0	0	0.6	15.7
Cash flow hedging \| Pre-issuance hedge contracts \| Interest expense
Effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, net of income tax effect
Net Gain (Loss) Reclassified from AOCI to Income (Loss)	$ (0.1)	$ (0.1)	$ (0.3)	$ (0.6)

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Debt and Investments (Details) $ in Millions, $ in Millions	Aug. 31, 2023 USD ($)	Apr. 30, 2023 CAD ($)	Feb. 28, 2023 USD ($)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, including current portion	$ 11,239.1		$ 11,296
Carrying amount
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, including current portion	11,239.1		11,296
Fair value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, including current portion	10,311.8		$ 10,236
Convertible debt securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Value of debt securities held, C$		$ 100
2018 Canopy Warrants
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair value of warrants	0
2023 Canopy Promissory Note
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair value of receivables	$ 0

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Recurring Basis Measurements (Details) - Recurring - USD ($) $ in Millions	Aug. 31, 2023	Feb. 28, 2023
Foreign currency contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	$ 334.8	$ 249.5
Derivative liability	12.3	17.2
Commodity derivative contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	17.9	25.8
Derivative liability	28.4	27.8
Equity securities
Fair Value, Net Asset (Liability) [Abstract]
Equity securities		0.2
Convertible debt securities
Fair Value, Net Asset (Liability) [Abstract]
Debt securities		69.6
Quoted Prices in Active Markets (Level 1) \| Foreign currency contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	0	0
Derivative liability	0	0
Quoted Prices in Active Markets (Level 1) \| Commodity derivative contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	0	0
Derivative liability	0	0
Quoted Prices in Active Markets (Level 1) \| Equity securities
Fair Value, Net Asset (Liability) [Abstract]
Equity securities		0
Quoted Prices in Active Markets (Level 1) \| Convertible debt securities
Fair Value, Net Asset (Liability) [Abstract]
Debt securities		0
Significant Other Observable Inputs (Level 2) \| Foreign currency contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	334.8	249.5
Derivative liability	12.3	17.2
Significant Other Observable Inputs (Level 2) \| Commodity derivative contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	17.9	25.8
Derivative liability	28.4	27.8
Significant Other Observable Inputs (Level 2) \| Equity securities
Fair Value, Net Asset (Liability) [Abstract]
Equity securities		0.2
Significant Other Observable Inputs (Level 2) \| Convertible debt securities
Fair Value, Net Asset (Liability) [Abstract]
Debt securities		69.6
Significant Unobservable Inputs (Level 3) \| Foreign currency contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	0	0
Derivative liability	0	0
Significant Unobservable Inputs (Level 3) \| Commodity derivative contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	0	0
Derivative liability	$ 0	0
Significant Unobservable Inputs (Level 3) \| Equity securities
Fair Value, Net Asset (Liability) [Abstract]
Equity securities		0
Significant Unobservable Inputs (Level 3) \| Convertible debt securities
Fair Value, Net Asset (Liability) [Abstract]
Debt securities		$ 0

Fair Value of Financial Instr_5

Fair Value of Financial Instruments - Nonrecurring Basis Measurements (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method investments, total losses	$ 12.3	$ 1,060.3	$ 135.8	$ 1,060.3
Nonrecurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method investments, total losses			135.8	1,060.3
Nonrecurring \| Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method investments	97.8	634.8	97.8	634.8
Nonrecurring \| Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method investments	2.6	0	2.6	0
Nonrecurring \| Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method investments	$ 0	$ 0	$ 0	$ 0

Fair Value of Financial Instr_6

Fair Value of Financial Instruments - Impairment of Equity Method Investments and Long-Lived Assets (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022	May 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method investments, total losses	$ 12.3	$ 1,060.3	$ 135.8	$ 1,060.3
Corporate Venture Capital, Equity Method Investments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method investments, carrying value	14.9		14.9
Equity method investments	2.6		2.6
Equity method investments, total losses	$ 12.3		12.3
Canopy Equity Method Investment
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method investments, carrying value		1,695.1		1,695.1	$ 266.2
Equity method investments		634.8		634.8	$ 142.7
Equity method investments, total losses		$ 1,060.3	$ 123.5	$ 1,060.3

Goodwill (Details)

Goodwill (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
Goodwill (Details) - USD ($) $ in Millions	Aug. 31, 2023	Feb. 28, 2023	Apr. 30, 2022	Mar. 31, 2022
Changes in the carrying amount of goodwill [Roll Forward]
Goodwill, beginning of period	$ 7,925.4	$ 7,862.4
Purchase accounting allocations	4.2	26.3
2022 Wine Divestiture		(24.5)
Foreign currency translation adjustments	56	61.2
Goodwill, end of period	7,985.6	7,925.4
Austin Cocktails Acquisition
Changes in the carrying amount of goodwill [Roll Forward]
Earn-out period			5 years
Lingua Franca Business Acquisition
Changes in the carrying amount of goodwill [Roll Forward]
Earn-out period				7 years
Operating Segments \| Beer
Changes in the carrying amount of goodwill [Roll Forward]
Goodwill, beginning of period	5,188.9	5,120.7
Purchase accounting allocations	0	0
2022 Wine Divestiture		0
Foreign currency translation adjustments	58.1	68.2
Goodwill, end of period	5,247	5,188.9
Operating Segments \| Wine and Spirits
Changes in the carrying amount of goodwill [Roll Forward]
Goodwill, beginning of period	2,736.5	2,741.7
Purchase accounting allocations	4.2	26.3
2022 Wine Divestiture		(24.5)
Foreign currency translation adjustments	(2.1)	(7)
Goodwill, end of period	$ 2,738.6	$ 2,736.5
Operating Segments \| Wine and Spirits \| Austin Cocktails Acquisition
Changes in the carrying amount of goodwill [Roll Forward]
Remaining equity interest			73%

Intangible Assets - Component o

Intangible Assets - Component of Intangible Assets (Details) - USD ($) $ in Millions	Aug. 31, 2023	Feb. 28, 2023
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, Gross Carrying Amount	$ 105.7	$ 106.5
Amortizable intangible assets, Net Carrying Amount	16.8	17.7
Indefinite-lived Intangible Assets [Line Items]
Intangible assets	2,734.5	2,728.1
Trademarks
Indefinite-lived Intangible Assets [Line Items]
Nonamortizable intangible assets, Net Carrying Amount	2,717.7	2,710.4
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, Gross Carrying Amount	85.3	85.7
Amortizable intangible assets, Net Carrying Amount	16.8	17.7
Other
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, Gross Carrying Amount	20.4	20.8
Amortizable intangible assets, Net Carrying Amount	$ 0	$ 0

Equity Method Investments (Deta

Equity Method Investments (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022	Feb. 28, 2023	Oct. 31, 2022
Schedule of Equity Method Investments [Line Items]
Equity method investments, carrying value	$ 277.1	$ 833.4	$ 277.1	$ 833.4	$ 663.3
Canopy Equity Method Investment
Schedule of Equity Method Investments [Line Items]
Equity method investments, carrying value	$ 134.8		$ 134.8		$ 485.8
Equity method investment, ownership percentage	27.40%		27.40%		34.70%
Fair value of equity method investment	$ 97.8		$ 97.8		$ 398.4
Equity method investment, in shares	171.5		171.5
Equity in earnings (loss) from Canopy and related activities	$ (12)	(650.7)	$ (231.8)	(815.7)
Canopy Equity Method Investment \| Third Party Investors
Schedule of Equity Method Investments [Line Items]
Ownership percentage						100%
Other equity method investments
Schedule of Equity Method Investments [Line Items]
Equity method investments, carrying value	142.3		142.3		$ 177.5
Equity in earnings (loss) from Canopy and related activities	$ 6.7	$ 1.2	$ 6.4	$ 0.7
Other equity method investments \| Minimum
Schedule of Equity Method Investments [Line Items]
Equity method investment, ownership percentage	20%		20%		20%
Other equity method investments \| Maximum
Schedule of Equity Method Investments [Line Items]
Equity method investment, ownership percentage	50%		50%		50%

Borrowings - Schedule of Borrow

Borrowings - Schedule of Borrowings (Details) - USD ($) $ in Millions	Aug. 31, 2023	Feb. 28, 2023
Schedule of Debt [Line Items]
Short-term borrowings	$ 467.4	$ 1,165.3
Long-term Debt
Other, current	9.1
Other, long-term	13.6
Other, total	22.7	26.2
Long-term debt, current	558.3	9.5
Long-term debt, long-term	10,680.8	11,286.5
Long-term debt, total	11,239.1	11,296
Unsecured debt \| Term loan credit facilities
Long-term Debt
Unsecured debt, current	0
Unsecured debt, long-term	0
Unsecured debt, total	0	799.2
Unsecured debt \| Senior notes
Long-term Debt
Unsecured debt, current	549.2
Unsecured debt, long-term	10,667.2
Unsecured debt, total	11,216.4	10,470.6
Commercial paper
Schedule of Debt [Line Items]
Short-term borrowings	$ 467.4	$ 1,165.3

Borrowings - Credit Agreements

Borrowings - Credit Agreements (Details) - USD ($)	Aug. 31, 2023	Feb. 28, 2023	Dec. 31, 2022
Schedule of Debt [Line Items]
Short-term borrowings	$ 467,400,000	$ 1,165,300,000
Revolving credit facility
Schedule of Debt [Line Items]
Short-term borrowings	$ 0
Weighted average interest rate	0%
Remaining borrowing capacity	$ 1,770,500,000
Aggregate principal amount	$ 2,250,000,000
Revolving credit facility \| SOFR
Schedule of Debt [Line Items]
SOFR margin	0%
Letters of credit
Schedule of Debt [Line Items]
Outstanding letters of credit	$ 11,500,000
Aggregate principal amount	200,000,000
Commercial paper
Schedule of Debt [Line Items]
Short-term borrowings	$ 467,400,000	$ 1,165,300,000
Weighted average interest rate	5.80%
Aggregate principal amount	$ 468,000,000		$ 2,250,000,000

Borrowings - Commercial Paper P

Borrowings - Commercial Paper Program (Details) - USD ($)	Aug. 31, 2023	Feb. 28, 2023	Dec. 31, 2022
Schedule of Debt [Line Items]
Short-term borrowings	$ 467,400,000	$ 1,165,300,000
Commercial paper
Schedule of Debt [Line Items]
Aggregate principal amount	468,000,000		$ 2,250,000,000
Short-term borrowings	$ 467,400,000	$ 1,165,300,000
Weighted average interest rate	5.80%
Weighted average remaining term	9 days

Borrowings - Senior Notes (Deta

Borrowings - Senior Notes (Details) $ in Millions	1 Months Ended
Borrowings - Senior Notes (Details) $ in Millions	May 31, 2023 USD ($)
Schedule of Debt [Line Items]
Basis spread on adjusted treasury rate	0.0025
4.90% May 2023 Senior Notes \| Senior Notes
Schedule of Debt [Line Items]
Aggregate principal amount	$ 750
Interest rates of notes	4.90%
Proceeds from issuance of debt	$ 739.8
Percentage of outstanding principal amount as redemption price	100%

Borrowings - Debt Payments (Det

Borrowings - Debt Payments (Details) $ in Millions	Aug. 31, 2023 USD ($)
Debt Disclosure [Abstract]
Unamortized debt issuance costs, long-term debt obligations	$ 59.1
Unamortized discount, long-term debt obligations	24.5
Fiscal 2024	5.6
Fiscal 2025	956.6
Fiscal 2026	1,405
Fiscal 2027	603.8
Fiscal 2028	1,801.6
Fiscal 2029	500
Thereafter	6,050.1
Total long-term debt, gross	$ 11,322.7

Income Taxes (Details)

Income Taxes (Details)	3 Months Ended		6 Months Ended
Income Taxes (Details)	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022
Income Tax Disclosure [Abstract]
Effective tax rate	17.40%	13.10%	22.10%	53.30%

Stockholders' Equity - Summary

Stockholders' Equity - Summary of Common Stock and Treasury Stock Issued (Details) - shares	3 Months Ended				6 Months Ended
	Aug. 31, 2023	May 31, 2023	Aug. 31, 2022	May 31, 2022	Aug. 31, 2023	Aug. 31, 2022
Class A Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, beginning of period (in shares)		212,697,428			212,697,428
Treasury Stock, beginning of period (in shares)		29,498,426			29,498,426
Number of shares repurchased (in shares)					153,937
Common Stock, end of period (in shares)	212,697,728				212,697,728
Treasury Stock, end of period (in shares)	29,038,592				29,038,592
Common Stock \| Class A Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, beginning of period (in shares)	212,697,508	212,697,428	187,264,514	187,263,859	212,697,428	187,263,859
Conversion of shares (in shares)	(220)	(80)	(2,196,749)	(655)
Common Stock, end of period (in shares)	212,697,728	212,697,508	189,461,263	187,264,514	212,697,728	189,461,263
Common Stock \| Class B Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, beginning of period (in shares)	0	0	28,211,685	28,212,340	0	28,212,340
Conversion of shares (in shares)				(655)
Common Stock, end of period (in shares)	0	0	28,211,685	28,211,685	0	28,211,685
Common Stock \| Class 1 Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, beginning of period (in shares)	23,425	22,705	2,248,714	2,248,679	22,705	2,248,679
Conversion of shares (in shares)	(220)	(80)	(2,196,749)
Exercise of stock options (in shares)	606	800		35
Common Stock, end of period (in shares)	23,811	23,425	51,965	2,248,714	23,811	51,965
Treasury Stock \| Class A Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury Stock, beginning of period (in shares)	29,438,466	29,498,426	26,694,497	22,824,607	29,498,426	22,824,607
Number of shares repurchased (in shares)		153,937	1,652,445	4,065,508
Exercise of stock options (in shares)	364,530	129,595	75,482	108,228
Employee stock purchases (in shares)	(30,172)		(27,514)
Treasury Stock, end of period (in shares)	29,038,592	29,438,466	28,239,095	26,694,497	29,038,592	28,239,095
Treasury Stock \| Class A Stock \| Restricted stock units
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of stock units (in shares)	(5,172)	(71,189)	(4,851)	(71,064)
Shares withheld to satisfy tax withholding requirements (in shares)	170	39,839	186	37,308	40,009	37,494
Treasury Stock \| Class A Stock \| Performance share units
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of stock units (in shares)		(13,113)		(16,326)
Shares withheld to satisfy tax withholding requirements (in shares)	0	8,735	0	4,919	8,735	4,919
Treasury Stock \| Class B Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury Stock, beginning of period (in shares)	0	0	5,005,800	5,005,800	0	5,005,800
Treasury Stock, end of period (in shares)	0	0	5,005,800	5,005,800	0	5,005,800

Stockholders' Equity - Narrativ

Stockholders' Equity - Narrative (Details)	1 Months Ended	3 Months Ended			6 Months Ended	32 Months Ended
Stockholders' Equity - Narrative (Details)	Nov. 30, 2022 USD ($) $ / shares	May 31, 2023 USD ($) shares	Aug. 31, 2022 USD ($) shares	May 31, 2022 USD ($) shares	Aug. 31, 2023 USD ($) shares	Aug. 31, 2023 USD ($) shares	Jan. 31, 2021 USD ($)
Equity, Class of Treasury Stock [Line Items]
Conversion of stock ratio	1
Payment to holders of Class B Stock in connection with the Reclassification	$ 1,500,000,000
Dollar Value of Shares Repurchased		$ 35,000,000	$ 392,900,000	$ 1,007,600,000
Treasury Stock
Equity, Class of Treasury Stock [Line Items]
Dollar Value of Shares Repurchased		$ 35,000,000	$ 392,900,000	$ 1,007,600,000
Class A and Class B \| 2021 Authorization
Equity, Class of Treasury Stock [Line Items]
Repurchase Authorization							$ 2,000,000,000
Class A Stock
Equity, Class of Treasury Stock [Line Items]
Number of shares repurchased (in shares) \| shares					153,937
Dollar Value of Shares Repurchased					$ 35,000,000
Class A Stock \| Treasury Stock
Equity, Class of Treasury Stock [Line Items]
Cash receivable per share held under reclassification agreement (in dollars per share) \| $ / shares	$ 64.64
Number of shares repurchased (in shares) \| shares		153,937	1,652,445	4,065,508
Class A Stock \| 2021 Authorization
Equity, Class of Treasury Stock [Line Items]
Number of shares repurchased (in shares) \| shares						4,985,847
Dollar Value of Shares Repurchased						$ 1,171,600,000

Stockholders' Equity - Stock Re

Stockholders' Equity - Stock Repurchases (Details) - USD ($)	3 Months Ended			6 Months Ended	32 Months Ended
	May 31, 2023	Aug. 31, 2022	May 31, 2022	Aug. 31, 2023	Aug. 31, 2023	Jan. 31, 2021
Equity, Class of Treasury Stock [Line Items]
Dollar Value of Shares Repurchased	$ 35,000,000	$ 392,900,000	$ 1,007,600,000
Class A and Class B \| 2021 Authorization
Equity, Class of Treasury Stock [Line Items]
Repurchase Authorization						$ 2,000,000,000
Class A Stock
Equity, Class of Treasury Stock [Line Items]
Dollar Value of Shares Repurchased				$ 35,000,000
Number of shares repurchased (in shares)				153,937
Class A Stock \| 2021 Authorization
Equity, Class of Treasury Stock [Line Items]
Dollar Value of Shares Repurchased					$ 1,171,600,000
Number of shares repurchased (in shares)					4,985,847

Net Income (Loss) Per Common _3

Net Income (Loss) Per Common Share Attributable to CBI (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended		6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022
Earnings per share reconciliation
Net income (loss) attributable to CBI allocated - basic	$ 690	$ (1,151.2)	$ 825.9	$ (761.7)
Basic and diluted net income (loss) per common share attributable to CBI
Antidilutive shares (in shares)			802	801
Class A Stock
Earnings per share reconciliation
Net income (loss) attributable to CBI allocated - basic	$ 690	(1,018.2)	$ 825.9	$ (674.2)
Conversion of Class B common shares into Class A common shares		0		0
Effect of stock-based awards on allocated net income (loss)		0		0
Net income (loss) attributable to CBI allocated - diluted		$ (1,018.2)		$ (674.2)
Weighted average number of shares outstanding reconciliation
Weighted average common shares outstanding - basic (in shares)	183,498	161,730	183,384	163,532
Conversion of Class B common shares into Class A common shares (in shares)		0		0
Stock-based awards, primarily stock options (in shares)	779	0	690	0
Weighted average common shares outstanding - diluted (in shares)	184,277	161,730	184,074	163,532
Basic and diluted net income (loss) per common share attributable to CBI
Net income (loss) per common share attributable to CBI - basic (in dollars per share)	$ 3.76	$ (6.30)	$ 4.50	$ (4.13)
Net income (loss) per common share attributable to CBI - diluted (in dollars per share)	$ 3.74	$ (6.30)	$ 4.49	$ (4.13)
Class B Stock
Earnings per share reconciliation
Net income (loss) attributable to CBI allocated - basic		$ (133)		$ (87.5)
Conversion of Class B common shares into Class A common shares		0		0
Effect of stock-based awards on allocated net income (loss)		0		0
Net income (loss) attributable to CBI allocated - diluted		$ (133)		$ (87.5)
Weighted average number of shares outstanding reconciliation
Weighted average common shares outstanding - basic (in shares)		23,206		23,206
Conversion of Class B common shares into Class A common shares (in shares)		0		0
Stock-based awards, primarily stock options (in shares)		0		0
Weighted average common shares outstanding - diluted (in shares)		23,206		23,206
Basic and diluted net income (loss) per common share attributable to CBI
Net income (loss) per common share attributable to CBI - basic (in dollars per share)		$ (5.73)		$ (3.77)
Net income (loss) per common share attributable to CBI - diluted (in dollars per share)		$ (5.73)		$ (3.77)
Antidilutive shares (in shares)			23,206	23,206

Comprehensive Income (Loss) A_3

Comprehensive Income (Loss) Attributable to CBI - Reconciliation of Net Income (Loss) Attributable to CBI to Comprehensive Income (Loss) Attributable to CBI (Details) - USD ($) $ in Millions	3 Months Ended				6 Months Ended
	Aug. 31, 2023	May 31, 2023	Aug. 31, 2022	May 31, 2022	Aug. 31, 2023	Aug. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Net income (loss) attributable to CBI	$ 690		$ (1,151.2)		$ 825.9	$ (761.7)
Other comprehensive income (loss) attributable to CBI
Other comprehensive income (loss) attributable to CBI, net of tax amount	200.8	$ 225.3	(193.5)	$ 259
Comprehensive income (loss) attributable to CBI	881.5		(1,340.3)		1,231.8	(704.4)
Accumulated Other Comprehensive Income (Loss)
Other comprehensive income (loss) attributable to CBI
Net gain (loss), net of tax amount					467.4
Reclassification adjustments, net of tax amount					(61.5)
Other comprehensive income (loss) attributable to CBI, before tax amount	195.8		(191.5)		417.2	65
Other comprehensive income (loss) attributable to CBI, tax (expense) benefit	(4.3)		2.4		(11.3)	(7.7)
Other comprehensive income (loss) attributable to CBI, net of tax amount	191.5	$ 214.4	(189.1)	$ 246.4	405.9	57.3
Accumulated Other Comprehensive Income (Loss) \| Share of OCI of Equity Method Investments
Other comprehensive income (loss) attributable to CBI
Net gain (loss), before tax amount	1.1		9.9		0.8	0.9
Net gain (loss), tax (expense) benefit	0		(0.4)		0.1	3.4
Net gain (loss), net of tax amount	1.1		9.5		0.9	4.3
Reclassification adjustments, before tax amount	0		0		0	0
Reclassification adjustments, tax (expense) benefit	0		0		0	0
Reclassification adjustments, net of tax amount	0		0		0	0
Other comprehensive income (loss) attributable to CBI, before tax amount	1.1		9.9		0.8	0.9
Other comprehensive income (loss) attributable to CBI, tax (expense) benefit	0		(0.4)		0.1	3.4
Other comprehensive income (loss) attributable to CBI, net of tax amount	1.1		9.5		0.9	4.3
Foreign Currency Translation Adjustments
Other comprehensive income (loss) attributable to CBI
Net gain (loss), before tax amount	160.2		(181.4)		323.6	(11.1)
Net gain (loss), tax (expense) benefit	0		0		0	0
Net gain (loss), net of tax amount	160.2		(181.4)		323.6	(11.1)
Reclassification adjustments, before tax amount	0		0		0	0
Reclassification adjustments, tax (expense) benefit	0		0		0	0
Reclassification adjustments, net of tax amount	0		0		0	0
Other comprehensive income (loss) attributable to CBI, before tax amount	160.2		(181.4)		323.6	(11.1)
Other comprehensive income (loss) attributable to CBI, tax (expense) benefit	0		0		0	0
Other comprehensive income (loss) attributable to CBI, net of tax amount	160.2		(181.4)		323.6	(11.1)
Unrealized Net Gain (Loss) on Derivative Instruments
Other comprehensive income (loss) attributable to CBI
Net gain (loss), before tax amount	76.4		(9.8)		162.8	95.7
Net gain (loss), tax (expense) benefit	(9.1)		1.7		(19.5)	(13.1)
Net gain (loss), net of tax amount	67.3		(8.1)		143.3	82.6
Reclassification adjustments, before tax amount	(41.7)		(10.3)		(69.5)	(20.3)
Reclassification adjustments, tax (expense) benefit	4.8		1		8	1.9
Reclassification adjustments, net of tax amount	(36.9)		(9.3)		(61.5)	(18.4)
Other comprehensive income (loss) attributable to CBI, before tax amount	34.7		(20.1)		93.3	75.4
Other comprehensive income (loss) attributable to CBI, tax (expense) benefit	(4.3)		2.7		(11.5)	(11.2)
Other comprehensive income (loss) attributable to CBI, net of tax amount	30.4		(17.4)		81.8	64.2
Pension/ Postretirement Adjustments
Other comprehensive income (loss) attributable to CBI
Net gain (loss), before tax amount	(0.2)		0.1		(0.5)	(0.2)
Net gain (loss), tax (expense) benefit	0		0.1		0.1	0.1
Net gain (loss), net of tax amount	(0.2)		0.2		(0.4)	(0.1)
Reclassification adjustments, before tax amount	0		0		0	0
Reclassification adjustments, tax (expense) benefit	0		0		0	0
Reclassification adjustments, net of tax amount	0		0		0	0
Other comprehensive income (loss) attributable to CBI, before tax amount	(0.2)		0.1		(0.5)	(0.2)
Other comprehensive income (loss) attributable to CBI, tax (expense) benefit	0		0.1		0.1	0.1
Other comprehensive income (loss) attributable to CBI, net of tax amount	$ (0.2)		$ 0.2		$ (0.4)	$ (0.1)

Comprehensive Income (Loss) A_4

Comprehensive Income (Loss) Attributable to CBI - Accumulated Other Comprehensive Income (Loss), Net of Income Tax Effect (Details) - USD ($) $ in Millions	3 Months Ended				6 Months Ended
	Aug. 31, 2023	May 31, 2023	Aug. 31, 2022	May 31, 2022	Aug. 31, 2023	Aug. 31, 2022
Accumulated other comprehensive income (loss), net of income tax effect [Roll Forward]
Stockholders' equity, beginning of period		$ 8,413.6			$ 8,413.6
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
Other comprehensive income (loss) attributable to CBI, net of tax amount	$ 200.8	225.3	$ (193.5)	$ 259
Stockholders' equity, period end	9,390.8				9,390.8
Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income (loss), net of income tax effect [Roll Forward]
Stockholders' equity, beginning of period		28.5			28.5
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
Other comprehensive income (loss) before reclassification adjustments					467.4
Amounts reclassified from accumulated other comprehensive income (loss)					(61.5)
Other comprehensive income (loss) attributable to CBI, net of tax amount	191.5	214.4	(189.1)	$ 246.4	405.9	$ 57.3
Stockholders' equity, period end	434.4				434.4
Accumulated Other Comprehensive Income (Loss) \| Share of OCI of Equity Method Investments
Accumulated other comprehensive income (loss), net of income tax effect [Roll Forward]
Stockholders' equity, beginning of period		10.3			10.3
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
Other comprehensive income (loss) before reclassification adjustments	1.1		9.5		0.9	4.3
Amounts reclassified from accumulated other comprehensive income (loss)	0		0		0	0
Other comprehensive income (loss) attributable to CBI, net of tax amount	1.1		9.5		0.9	4.3
Stockholders' equity, period end	11.2				11.2
Foreign Currency Translation Adjustments
Accumulated other comprehensive income (loss), net of income tax effect [Roll Forward]
Stockholders' equity, beginning of period		(176.4)			(176.4)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
Other comprehensive income (loss) before reclassification adjustments	160.2		(181.4)		323.6	(11.1)
Amounts reclassified from accumulated other comprehensive income (loss)	0		0		0	0
Other comprehensive income (loss) attributable to CBI, net of tax amount	160.2		(181.4)		323.6	(11.1)
Stockholders' equity, period end	147.2				147.2
Unrealized Net Gain (Loss) on Derivative Instruments
Accumulated other comprehensive income (loss), net of income tax effect [Roll Forward]
Stockholders' equity, beginning of period		198.5			198.5
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
Other comprehensive income (loss) before reclassification adjustments	67.3		(8.1)		143.3	82.6
Amounts reclassified from accumulated other comprehensive income (loss)	(36.9)		(9.3)		(61.5)	(18.4)
Other comprehensive income (loss) attributable to CBI, net of tax amount	30.4		(17.4)		81.8	64.2
Stockholders' equity, period end	280.3				280.3
Pension/ Postretirement Adjustments
Accumulated other comprehensive income (loss), net of income tax effect [Roll Forward]
Stockholders' equity, beginning of period		$ (3.9)			(3.9)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
Other comprehensive income (loss) before reclassification adjustments	(0.2)		0.2		(0.4)	(0.1)
Amounts reclassified from accumulated other comprehensive income (loss)	0		0		0	0
Other comprehensive income (loss) attributable to CBI, net of tax amount	(0.2)		$ 0.2		(0.4)	$ (0.1)
Stockholders' equity, period end	$ (4.3)				$ (4.3)

Business Segment Information -

Business Segment Information - Narrative (Details)	3 Months Ended	6 Months Ended
Business Segment Information - Narrative (Details)	May 31, 2023 segment division	Aug. 31, 2023 segment division
Segment Reporting [Abstract]
Number of business divisions \| division	3	2
Number of reportable operating segments \| segment	4	3

Business Segment Information _2

Business Segment Information - Comparable Adjustments (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022
Cost of product sold
Net gain (loss) on undesignated commodity derivative contracts	$ 28.9	$ (24.2)	$ 6.9	$ 30.5
Comparable Adjustments, Cost of product sold	(1,386.9)	(1,329.2)	(2,644)	(2,437.4)
Selling, general, and administrative expenses
Comparable Adjustments, Selling, general, and administrative expenses	(471.2)	(512.8)	(964.3)	(951.4)
Comparable Adjustments
Cost of product sold
Flow through of inventory step-up	(0.8)	(0.9)	(1.5)	(1.9)
Net flow through of reserved inventory	0	1.2	0	1.2
Recovery of (loss on) inventory write-down	0	0	0	0.2
Comparable Adjustments, Cost of product sold	23.9	(46.4)	(10.9)	(22)
Selling, general, and administrative expenses
Restructuring and other strategic business development costs	(3.4)	(1.2)	(18.3)	(2.6)
Transition services agreements activity	(7)	(4.5)	(12.7)	(7.9)
Transaction, integration, and other acquisition-related costs	(0.3)	(0.5)	(0.6)	(0.7)
Costs associated with the Reclassification	0	(20.6)	0.2	(21.3)
Other gains (losses)	(2.3)	3.6	(9.3)	8.8
Comparable Adjustments, Selling, general, and administrative expenses	(13)	(23.2)	(40.7)	(23.7)
Comparable Adjustments, Operating income (loss)	10.9	(69.6)	(51.6)	(45.7)
Gain (loss) on sale of business	(7.9)	0	(14.9)	0
Recognition of a previously deferred gain upon release of a related indemnity	5.6	0	5.6	0
Decreases in estimated fair values of contingent liabilities associated with prior period acquisitions	0	4.4	0	4.4
Comparable Adjustments \| Austin Cocktails Acquisition
Selling, general, and administrative expenses
Gain from remeasurement of previously held equity method investments	0	0	0	5.2
Comparable Adjustments \| Commodity derivative contracts
Cost of product sold
Net gain (loss) on undesignated commodity derivative contracts	19.1	(15.4)	(15.6)	33.1
Settlements of undesignated commodity derivative contracts	$ 5.6	$ (31.3)	$ 6.2	$ (54.6)

Business Segment Information _3

Business Segment Information - Segment Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022	Feb. 28, 2023
Segment Reporting Information [Line Items]
Net sales	$ 2,836.8	$ 2,655.1	$ 5,351.7	$ 5,018.3
Segment operating income (loss)	978.7	813.1	1,743.4	1,629.5
Income (loss) from unconsolidated investments	(20.2)	(1,719.1)	(435.6)	(1,907)
Equity method investments	277.1	833.4	277.1	833.4	$ 663.3
Capital expenditures	305	238.4	582	435
Depreciation and amortization	108.7	91.7	214.4	185.4
Gain (Loss) on Investments, Excluding Other than Temporary Impairments [Abstract]
Impairment of equity method investments	(12.3)	(1,060.3)	(135.8)	(1,060.3)
Unrealized net gain (loss) on securities measured at fair value	(2.6)	(9.3)	(74.4)	(31.7)
Income (loss) from unconsolidated investments	(20.2)	(1,719.1)	(435.6)	(1,907)
Canopy Equity Method Investment
Segment Reporting Information [Line Items]
Equity method investments	134.8		134.8		485.8
Gain (Loss) on Investments, Excluding Other than Temporary Impairments [Abstract]
Impairment of equity method investments		(1,060.3)	(123.5)	(1,060.3)
Equity in earnings (losses) of equity method investees and related activities	(12)	(650.7)	(231.8)	(815.7)
Other equity method investments
Segment Reporting Information [Line Items]
Equity method investments	142.3		142.3		$ 177.5
Gain (Loss) on Investments, Excluding Other than Temporary Impairments [Abstract]
Equity in earnings (losses) of equity method investees and related activities	6.7	1.2	6.4	0.7
Operating Segments \| Beer
Segment Reporting Information [Line Items]
Net sales	2,392.7	2,139.3	4,491.3	4,037.5
Segment operating income (loss)	953.9	865.6	1,751.7	1,628.4
Capital expenditures	234.7	196	440.3	357.8
Depreciation and amortization	81.4	67	160.2	135.2
Operating Segments \| Wine and Spirits
Segment Reporting Information [Line Items]
Net sales	444.1	515.8	860.4	980.8
Segment operating income (loss)	80.7	99.4	160	190.4
Income (loss) from unconsolidated investments	8.3	3.4	10.6	4.9
Equity method investments	104.4	100.5	104.4	100.5
Capital expenditures	38.9	21.8	77.5	51.6
Depreciation and amortization	23.1	21	45.6	43.3
Gain (Loss) on Investments, Excluding Other than Temporary Impairments [Abstract]
Income (loss) from unconsolidated investments	8.3	3.4	10.6	4.9
Operating Segments \| Wine and Spirits \| Wine
Segment Reporting Information [Line Items]
Net sales	383.9	442	744.9	846.1
Operating Segments \| Wine and Spirits \| Spirits
Segment Reporting Information [Line Items]
Net sales	60.2	73.8	115.5	134.7
Operating Segments \| Corporate Operations and Other
Segment Reporting Information [Line Items]
Segment operating income (loss)	(66.8)	(82.3)	(116.7)	(143.6)
Income (loss) from unconsolidated investments	(21.1)	(37)	(54.4)	(91)
Equity method investments	172.7	732.9	172.7	732.9
Capital expenditures	31.4	20.6	64.2	25.6
Depreciation and amortization	4.2	3.7	8.6	6.9
Gain (Loss) on Investments, Excluding Other than Temporary Impairments [Abstract]
Income (loss) from unconsolidated investments	(21.1)	(37)	(54.4)	(91)
Comparable Adjustments
Segment Reporting Information [Line Items]
Segment operating income (loss)	10.9	(69.6)	(51.6)	(45.7)
Income (loss) from unconsolidated investments	(7.4)	(1,685.5)	(391.8)	(1,820.9)
Gain (Loss) on Investments, Excluding Other than Temporary Impairments [Abstract]
Income (loss) from unconsolidated investments	$ (7.4)	$ (1,685.5)	$ (391.8)	$ (1,820.9)